Faculty Collaboration Database

1. Gutterman DD, Rusch NJ, Hermsmeyer K, Dole WP: Differential Reactivity to 5-Hydroxytryptamine in Canine Coronary Arteries. Blood Vessels. 23:165-172, 1986.

2. Gutterman DD, Chilian WM, Eastham CL, Inou T, White CW, Marcus ML: Failure of Pyruvate to Salvage Myocardium after Prolonged Ischemia. Am J Physiol. (Heart Circ. Physiol.) 19(1):H114-H120, 1986.

3. Bonham AC, Gutterman DD, Arthur JA, Marcus ML, Gebhart GF, Brody MJ. Electrical Stimulation in Pericortical Lateral Hypothalamus Decreases Coronary Blood Flow in Cat. Am J Physiol. 252:H474-H484, 1987.

4. Bonham AC, Gutterman DD, Arthur JM, Marcus ML, Gebhart GF, Brody MJ. Neurogenic Regulation of Coronary Blood Flow: Evidence for a Central Nervous System Pathway. Circ Res. 61(Suppl. II):II-42-II-46, 1987.

5. Gutterman DD, Bonham AC, Arthur JM, Gebhart GF, Marcus ML, Brody MJ. Characterization of a coro¬nary vasoconstrictor site in medullary reticular formation. Am J Physiol 1989 Apr;256(4 Pt 2):H1218-27.

6. Gutterman DD, Bonham AC, Gebhart GF, Marcus ML, Brody MJ. Connections between Hypothalamus and Medullary Reticular Formation Mediate Coronary Vasoconstriction. Am J Physiol. 259:H917-H924, 1990.

7. Arthur JM, Bonham AC, Gutterman DD, Gebhart GF, Marcus ML, Brody MJ. Coronary Vasoconstriction During Stimulation in the Hypothalamic Defense Region. Am J Physiol. 260:R335-R345, 1991.

8. Gutterman DD, Pardubsky PD, Clothier JL, Marcus ML, Brody MJ. Coronary Vasoconstriction in Response to Epicardial Hypothermia. Coronary Artery Disease. 2:75-86, 1991.

9. Gutterman DD, Gebhart GF, Pardubsky PD, Clothier J, Arthur SA, Marcus ML, Brody MJ. Role of Medullary Lateral Reticular Formation in Baroreflex Coronary Vasoconstriction. Brain Res. 557:202-209, 1991.

10. Miller FM, Brody MJ, Marcus ML, Gutterman DD. Activation in the region of Parabrachial Nucleus Elicits Neurogeni¬cally Mediated Coronary Vasoconstriction. Am J Physiol. 261:H1585-1596, 1991.

11. Jones LF, Gutterman DD, Brody MD. Patterns of Hemodynamic Responses Associated with Central Activation of Coronary Vasoconstriction. Am J Physiol. 262:R276-R283, 1992.

12. Gutterman DD, Morgan DA, Miller FM. Effect of Brief Myocardial Ischemia on Sympathetic Coronary Vasocon¬striction. Circ Res 71:960-969, 1992.

13. Ben-Haim SA, Becker B, Gutterman DD, Kaplinsky E, Palti Y. Prediction of Immediate Ventricular Arrhyth¬mias Following Coronary Artery Ligation. J Am Coll Cardiol. 20(5):1270-1276, 1992.

14. DeBoel SL, Gutterman DD. Coronary Vascular Response to Cerebral Ischemia Reflex. Hypertension. 21:216-221, 1993.

15. Goodson AR, LaMaster TS, Gutterman DD. Coronary Vasoconstrictor Pathway from Anterior Hypothalamus Includes Neurons in Rostroventrolateral Medulla. Am J Physiol. 265:R1311-R1317, 1993.

16. Goodson AR, Leibold JM, Gutterman DD. Inhibition of Nitric Oxide Synthesis Augments Centrally-Induced Sympathetic Coronary Vasoconstriction in Cats. Am. J. Physiol. 267:H1272-1278, 1994.

17. Pettersen MD, Abe T, Morgan DA, Gutterman DD. Role of Adenosine in Postischemic Dysfunction of Coronary Innervation. Circ Res. 76:95-101, 1995.

18. Scott I, Gutterman DD. Pheochromocytoma with Reversible Focal Cardiac Dysfunction. Am Heart J. 130(4):909-911, 1995.

19. Gutterman DD, Morgan DA. Transmural Regulation of Myocardial Perfusion by Neuropeptide Y. Basic Res. Cardiol. 90:348-355, 1995.

20. McDermott DA, Meller ST, Gebhart GF, Gutterman DD. Use of an Indwelling Catheter for Examining Cardiovascular Reponses to Pericardial Administration of Bradykinin in Rat. Cardiovascular Research. 30(1):39-46, July, 1995.

21. Gutterman DD, Goodson AR. The Role of Parabrachial Nucleus in Baroreflex Mediated Coronary Vasoconstriction. Am J Physiol. 271:H1079-H1086, 1996.

22. Abe T, Morgan DA, Gutterman DD. Role of Adenosine Receptor Subtypes in Neural Stunning of the Sympathetic Coronary Innervation. Am J Physiol. 272:H25-H34, 1997.

23. Abe T, Morgan DA, Gutterman DD. Protective Role of Nerve Growth Factor Against Postischemic Dysfunction of Sympathetic Coronary Innervation. Circulation. 95:213-220, 1997.

24. Miller FJ, Dellsperger KC, Embrey RP, Gutterman DD. Myogenic Constriction of Human Coronary Arterioles. Am J Physiol. 273: H257-H264, 1997.

25. Miura H, Morgan DA, Gutterman DD. Oxygen-Derived Free Radicals Contribute to Neural Stunning in the Canine Heart. Am J Physiol. 273:H1569-H1575, 1997.

26. Oltman C, Gutterman DD, Scott EC, Bocker JM, Dellsperger KC. Effects of glycosylated hemoglobin on vascular responses in vitro. Cardiovasc Res 1997 Apr;34(1): 179-84.

27. Gutterman DD, Pardubsky PD, Pettersen M, Marcus ML, Gebhart GF. Thoracic spinal neuron response to repeated myocardial ischemia and epicardial bradykinin. Brain Res 1998 Apr 20;790(1-2):293-303.

28. Miller FJ Jr, Dellsperger KC, Gutterman DD. Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine. Cardiovascular Res 1998 Jun;38(3):744-50.

29. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998 Jun 29;82(12):1298-305.

30. Abe T, Morgan D, Sengupta JN, Gebhart GF, Gutterman DD. Attenuation of ischemia-induced activation of cardiac sympathetic afferents following brief myocardial ischemia in cats. J Auton Nerv Syst. 1998 Jun 30;71(1):28-36.

31. Miura H, Gutterman DD. Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels. Circ Res 1998 Sep 7;83(5):501-7.

32. Miura H, Liu Y, Gutterman DD. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. Circulation 1999 June 22;99(24):3132-8.

33. Terata K, Coppey LJ, Davidson EP, Dunlap JA, Gutterman DD, Yorek MA. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. Br J Pharmacol 1999 Oct;128(3):837-43. PMCID: PMC1571695

34. Oltman CL, Kane NL, Gutterman DD, Bar RS, Dellsperger KC. Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size. Am J Physiol Endocrinol Metab 2000 Jul; 279(1):E176-81.

35. Ammar RF Jr, Gutterman DD, Brooks LA, Dellsperger KC. Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes. Cardiovasc Res 2000 Aug 18;47(3):595-601.

36. Ammar RF Jr, Gutterman DD, Brooks LA, Dellsperger KC. Impaired dilation of coronary arterioles during increases in myocardial O2 consumption with hyperglycemia. Am J Physiol Endocrinol Metab 2000 Oct;279(4):E868-74.

37. Terata K, Miura H, Liu Y, Loberiza F, Gutterman DD. Human coronary arteriolar dilation to adrenomedullin: role of nitric oxide and K(+) channels. Am J Physiol Heart Circ Physiol 2000 Dec;279(6):H2620-6.

38. Miura H, Wachtel RE, Liu Y, Loberiza FR Jr, Saito T, Miura M, Gutterman DD. Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+)-channels. Circulation 2001 Apr 17;103(15):1992-8.

39. Nair BA, Murad YZ, Brody MJ, Gutterman DD. Ouabain-induced coronary vasoconstriction in cats is not neurally mediated. Clin Exp Pharmacol Physiol 2001 Jul;28(7):510-7.

40. Bocker JM, Miller FJ, Oltman CL, Chappell DA, Gutterman DD. Calcium-activated potassium channels mask vascular dysfunction associated with oxidized LDL exposure in rabbit aorta. Japanese Heart J 2001 May;42(3):317-26.

41. Liu YP, Terata K, Rusch NJ, Gutterman DD. High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res 2001 Jul 20;89(2):146-52.

42. Sato A, Miura H, Liu Y, Somberg LB, Otterson MF, Demeure MJ, Schulte WJ, Eberhardt LM, Loberiza FR, Sakuma I, Gutterman DD. Effect of gender on endothelium-dependent dilation to bradykinin in human adipose microvessels. Am J Physiol Heart Circ Physiol 2002 Sep;283(3):H845-52.

43. Liu Y, Terata K, Chai Q, Li H, Kleinman LH, Gutterman DD. Peroxynitrite inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles. Circ Res 2002 Nov 29;91(11):1070-6.

44. Dart RA, Gregoire JR, Gutterman DD, Woolf SH. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest 2003 Jan;123(1):244-60.

45. Miura H, Wachtel RE, Loberiza, FR Jr, Saito T, Miura M, Nicolosi AC, Gutterman DD. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res 2003 Feb 7;92(2):151-8.

46. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 2003 Feb 7;92(2):e31-40.

47. Hoch AZ, Dempsey RL, Carrera GF, Wilson CR, Chen EH, Barnabei VM, Sandford PR, Ryan TA, Gutterman DD. Is there an association between athletic amenorrhea and endothelial cell dysfunction? Med Sci Sports Exerc, 2003 Mar;35(3):377-83.

48. Bosnjak JJ, Terata K, Miura H, Sato A, Nicolosi AC, McDonald M, Manthei SA, Saito T, Hatoum OA, Gutterman DD. Mechanism of thrombin-induced vasodilation in human coronary arterioles. Am J Physiol Heart Circ Physiol 2003 Apr;284(4): H1080-6.

49. Ou J, Ou Z, Jones DW, Holtzhauer S, Hatoum OA, Ackerman AW, Weihrauch DW, Gutterman DD, Guice K, Oldham KT, Hillery CA, Pritchard KA Jr. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Circulation 2003 May;107(18):2337-41.

50. Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 2003 Jul;125(1):58-69.

51. Peles S, Petersen J, Aviv R, Policker S, Abu-Hatoum O, Ben-Haim SA, Gutterman DD, Sengupta JN. Enhancement of antral contractions and vagal afferent signaling with synchronized electrical stimulation. Am J Physiol Gastrointest Liver Physiol 2003 Sep;285(3):G577-85.

52. Li H, Chai Q, Gutterman DD, Liu Y. Elevated glucose impairs cAMP-mediated dilation by reducing Kv channel activity in rat small coronary smooth muscle cells. Am J Physiol Heart Circ Physiol 2003 Sep;258(3):H1213-9.

53. Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, Gutterman DD. Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 2003 Sep 19;93(6):573-80.

54. Oltman CL, Clark CB, Kane NL, ZhangY, Gutterman DD, Dellsperger KC, Kerber RE. Coronary vascular dysfunction associated with direct current shock injury. Basic Res Cardiol 2003 Nov;98(6):406-15.

55. Sato A, Sakuma I, Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2345-54.

56. McGoon M, Gutterman DD, Steen V, Barst RJ, McCrory DC, Fortin TA, Loyd JE. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004 Jul;126(1 Suppl):14S-34S.

57. Stein PD, Schünemann HJ, Dalen JE, Gutterman DD. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 Sep;126(3 Suppl):600S-608S.

58. Li H, Gutterman DD, Rusch NJ, Bubolz A, Liu Y. Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose. Diabetes 2004 Sep;53(9):2436-42.

59. Hatoum OA, Binion DG, Miura H, Telford G, Otterson MF, Gutterman DD. Role of hydrogen peroxide in ACh-induced dilation of human submucosal intestinal microvessels. Am J Physiol Heart Circ Physiol 2005 Jan; 288(1): H48-54.

60. Slyper A, Jurva J, Pleuss J, Hoffmann R, Gutterman DD. Influence of glycemic load on HDL cholesterol in youth. Am J Clin Nutr 2005 Feb;81(2):376-9.

61. Sato A, Terata K, Miura H, Toyama K, Loberiza FR Jr, Hatoum OA, SaitoT, Sakuma I, Gutterman DD. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am J Physiol Heart Circ Physiol 2005 Apr;288(4):H1633-40.

62. Slyper A, Le A, Jurva J, Gutterman DD. The influence of lipoproteins on whole-blood viscosity at multiple shear rates. Metabolism 2005 Jun;54(6):764-8.

63. Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA. Epidemiology, mechanisms, and risks: ACCP guidelines for the prevention and management of post-operative atrial fibrillation after cardiac surgery. Chest. 2005 Aug;128(2 Suppl):9S-16S.

64. Epstein AE, Alexander JC, Gutterman DD, Maisel W, Wharton JM. Anticoagulation: ACCP guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005 Aug;128(2 Suppl):24S-27S.

65. Hatoum OA, Gauthier KM, Binion DG, Miura H, Telford G, Otterson MF, Campbell WB, Gutterman DD. Novel mechanism of vasodilation in inflammatory bowel disease. ATVB 2005 Nov;25(11):2355-61.

66. Hatoum OA, Binion DG, Phillips SA, O'Loughlin C, Komorowski RA, Gutterman DD, Otterson MF. Radiation induced small bowel "web" formation is associated with acquired microvascular dysfunction. Gut 2005 Dec;54(12):1797-800. PMCID: PMC1774807

67. Liu Y, Bubolz AH, Shi Y, Newman PJ, Newman DK, Gutterman DD. Peroxynitrite reduces the endothelium-derived hyperpolarizing factor component of coronary flow-mediated dilation in PECAM-1-knockout mice. Am J Physiol Regul Integr Comp Physiol 2006 Jan;290(1):R57-65.

68. Guyatt G, Gutterman DD, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schünemann H. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest. 2006 Jan;129(1): 174-81.

69. Guyatt G, Baumann M, Pauker S, Halperin J, Maurer J, Owens DK, Tosteson AN, Carlin B, Gutterman DD, Prins M, Lewis SZ, Schünemann H. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest. 2006 Jan;129(1):182-7.

70. Larsen BT, Miura H, Hatoum OA, Campbell WB, Hammock BD, Zeldin DC, Falck JR, Gutterman DD. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels: implications for soluble epoxide hydrolase inhibition. Am J Physiol Heart Circ Physiol 2006 Feb;290(2): H491-9. PMCID: PMC1456013

71. Hatoum OA, Otterson MF, Kopelman D, Miura H, Sukhotnik I, Larsen BT, Selle RM, Moulder JE, Gutterman DD. Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species. ATVB 2006 Feb;26(2):287-94.

72. Dedkov EI, Perloff JK, Tomanek RJ, Fishbein MC, Gutterman DD. The coronary microcirculation in cyanotic congenital heart disease. Circulation 2006 Jul 18;114(3):196-200.

73. Jurva JW, Phillips SA, Syed AQ, Syed AY, Pitt S, Weaver A, Gutterman DD. The effect of exertional hypertension evoked by weight lifting on vascular endothelial function. JACC 2006 Aug 1;48(3):588-9.

74. Dhanasekaran A, Al-Saghir R, Lopez B, Zhu D, Gutterman DD, Jacobs ER, Medhora M. Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature. Am J Physiol Heart Circ Physiol 2006 Aug;291(2):H517-31.

75. Phillips SA, Hatoum OA, Gutterman DD. The mechanism of flow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD. Am J Physiol Heart Circ Physiol 2007 Jan;292(1):H93-100.

76. Baumann MH, Lewis SZ, Gutterman DD. ACCP evidence-based guideline development: a successful and transparent approach to addressing conflict of interest, funding, and patient-centered recommendations. Chest 2007 Sep;132(3): 1015-24.

77. Bubolz AH, Wu Q, Larsen BT, Gutterman DD, Liu Y. Ebselen reduces nitration and restores voltage-gated potassium channel function in small coronary arteries of diabetic rats. Am J Physiol Heart Circ Physiol 2007 Oct;293(4): H2231-7.

78. Hoch AZ, Jurva JW, Staton MA, Thielke R, Hoffmann RG, Pajewski N, Gutterman DD. Athletic amenorrhea and endothelial dysfunction. WMJ 2007 Sep;106(6):301-6.

79. Larsen BT, Gutterman DD, Sato A, Toyama K, Campbell WB, Zeldin DC, Manthati VL, Falck JR, Miura H. Hydrogen peroxide inhibits cytochrome P450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors. Circ Res 2008 Jan 4;102(1): 59-67. PMCID: PMC2364729

80. Phillips SA, Jurva JW, Syed AQ, Syed AQ, Kulinski JP, Pleuss J, Hoffmann RG, Gutterman DD. Benefit of low-fat over low-carbohydrate diet on endothelial health in obesity. Hypertension 2008 Feb;51(2):376-82. PMCID: PMC2702133. Winner of the Award for Most Significant Original Paper for 2008 in the category of Clinical Science.

81. Mio Y, Bienengraeber MW, Marinovic J, Gutterman DD, Rakic M, Bosnjak ZJ, Stadnicka A. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. Anesthesiology 2008 Apr;108(4):612-20. PMCID: PMC2697447

82. Liu Y, Li H, Bubolz AH, Zhang DX, Gutterman DD. Endothelial cytoskeletal elements are critical for flow-mediated dilation in human coronary arterioles. Med Biol Eng Comput 2008 May;46(5):469-78. PMCID: PMC2702135

83. Harrington, RA, Becker RC, Cannon CP, Gutterman DD, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG, American College of Chest Physicians. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):670S-707S.

84. Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, Fujiwara Y, Mattson DL, Das S, Melvin JE, Pratt PF, Hatoum OA, Gutterman DD, Harder DR, Miura H. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest 2008 Sep;118(9):3025-37. PMCID: PMC2496961

85. Farrell RM, Syed A, Syed A, Gutterman DD. Effects of limb electrode placement on the 12- and 16-lead electrocardiogram. J Electrocardiol 2008 Nov-Dec;41(6):536-45.

86. Zhang DX, Mendoza SA, Bubolz AH, Mizuno A, Ge ZD, Li R, Warltier DC, Suzuki M, Gutterman DD. Transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo. Hypertension 2009 Mar;53(3):532-8. PMCID: PMC2694062

87. Hoch AZ, Pajewski NM, Hoffman RG, Schimke JE, Gutterman DD. Possible relationship of folic acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrhiec athletic women. J Sports Science & Medicine 2009 Mar;8(1):123-9.

88. Larsen BT, Bubolz AH, Mendoza SA, Pritchard KA Jr, Gutterman DD. Bradykinin-induced dilation of human coronary arterioles requires NADPH oxidase-derived reactive oxygen species. ATVB 2009 May;29(5):739-45. PMCID: PMC2727937

89. Migrino RQ, Hari P, Gutterman DD, Bright M, Truran S, Schlundt B, Phillips SA. Systemic and microvascular oxidative stress induced by light chain amyloidosis. Int J Cardiol 2010 Nov 5;145(1):67-8. PMCID: PMC2974792

90. Bodiga S, Zhang R, Jacobs DE, Larsen BT, Tampo A, Manthati VL, Kwok WM, Zeldin DC, Falck JR, Gutterman DD, Jacobs ER, Medhora MM. Protective actions of epoxyeicosatrienoic acid: Dual targeting of cardiovascular PI3K and KATP channels. J Mol Cell Cardiol. 2009 Jun;46(6):978-88. PMCID: PMC2796716

91. Hoch AZ, Pajewski NM, Moraski L, Carrera GF, Wilson CR, Hoffmann RG, Schimke JE, Gutterman DD. Prevalence of the female athlete triad in high school athletes and sedentary students. Clin J Sport Med. 2009 Sep;19(5):421-8. PMCID: PMC2848387

92. Mendoza SA, Fang J, Gutterman DD, Wilcox DA, Bubolz AH, Li R, Suzuki M, Zhang DX. TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H466-76. PMCID: PMC2822567

93. Hoch AZ, Lynch SL, Jurva JW, Schimke JE, Gutterman DD. Folic acid supplementation improves vascular function in amenorrheic runners. Clin J Sport Med. 2010 May;20(3):205-10.

94. Widlansky ME, Wang J, Shenouda SM, Hagen TM, Smith AR, Kizhakekuttu TJ, Kluge MA, Weihrauch D, Gutterman DD, Vita JA. Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. Transl Res. 2010 Jul;156(1):15-25. PMCID: PMC2904361

95. Kizhakekuttu TJ, Gutterman DD, Phillips SA, Jurva JW, Arthur EIL, Das E, Widlansky ME. Measuring FMD in the Brachial Artery: How important is QRS-gating? J Appl Physiol. 2010 Oct;109(4):959-65. PMCID: PMC2963331

96. Miura H, Toyama K, Pratt PF Jr, Gutterman DD. Cigarette smoking impairs sodium-potassium ATPase activity in the human coronary microcirculation. Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H109-17. PMCID: PMC3023254

97. Liu Y, Bubolz AH, Mendoza S, Zhang DX, Gutterman DD. H2O2 Is the Transferrable Factor Mediating Flow-Induced Dilation in Human Coronary Arterioles. Circ Res. 2011;108:566-573. PMCID: PMC3108183

98. Phillips SA, Das E, Wang J, Pritchard KA, Gutterman DD. Resistance and aerobic exercise protects against acute endothelial impairment induced by a single exposure to hypertension during exertion. J Appl Physiol. 2011 Apr;110(4):1013-20. PMCID: PMC3075126

99. Hoch AZ, Papanek P, Szabo A, Widlansky ME, Schimke JE, Gutterman DD. Association between the female athlete triad and endothelial dysfunction in dancers. Clin J Sport Med. 2011 Mar;21(2):119-25.

100. Migrino RQ, Truran S, Gutterman DD, Franco DA, Bright M, Schlundt B, Timmons M, Motta A, Phillips SA, Hari P. Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins. Am J Physiol Heart Circ Physiol. 2011 Sep 30. PMCID: PMC3233808

101. Gauthier KM, Olson L, Harder A, Isbell M, Imig JD, Gutterman DD, Campbell WB. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles. Am J Physiol Renal Physiol. 2011 Oct;301(4):F765-72. PMCID: PMC3191800

102. Hoch AZ, Papanek P, Szabo A, Widlansky ME, Gutterman DD. Folic Acid Supplementation Improves Vascular Function in Professional Dancers With Endothelial Dysfunction. PM R. 2011 Nov;3(11):1005-12. PMCID: PMC3328806

103. Zhang DX, Borbouse L, Gebremedhin D, Mendoza SA, Zinkevich NS, Li R, Gutterman DD. H2O2-Induced Dilation in Human Coronary Arterioles: Role of Protein Kinase G Dimerization and Large-Conductance Ca2+-Activated K+ Channel Activation. Circ Res. 2012, 110(3):471-480. PMCID: PMC3272100

104. Dharmashankar K, Welsh A, Wang J, Kizhakekuttu TJ, Ying R, Gutterman DD, Widlansky ME. Nitric Oxide Synthase-Dependent Vasodilation of Human Subcutaneous Arterioles Correlates With Noninvasive Measurements of Endothelial Function. Am J Hypertens. 2012 May;25(5):528-34. PMCID: PMC3328603

105. Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P, Akl EA, Lansberg MG, Guyatt GH, Spencer FA Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e637S-68S.

106. Guyatt GH, Norris SL, Schulman S, Hirsh J, Eckman MH, Akl EA, Crowther M, Vandvik PO, Eikelboom JW, McDonagh MS, Lewis SZ, Gutterman DD, Cook DJ, Schünemann HJ. Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):53S-70S.

107. Bubolz AH, Mendoza SA, Zheng X, Zinkevich NS, Li R, Gutterman DD, Zhang DX. Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signaling. Am J Physiol Heart Circ Physiol. 2012 Feb;302(3):H634-42.

108. Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar K, Vasquez-Vivar J, Gutterman DD, Widlansky ME. Acute Exposure to Low Glucose Rapidly Induces Endothelial Dysfunction and Mitochondrial Oxidative Stress: Role for AMP Kinase. Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):712-20. PMCID: PMC3319449

109. Tonelli MR, Curtis JR, Guntupalli KK, Rubenfeld GD, Arroliga AC, Brochard L, Douglas IS, Gutterman DD, Hall JR, Kavanagh BP, Mancebo J, Misak CJ, Simpson SQ, Slutsky AS, Suffredini AF, Thompson BT, Ware LB, Wheeler AP, Levy MM, on behalf of the ACCP/ATS/SCCM Working Group. An Official Multi-Society Statement: The Role of Clinical Research Results in the Practice of Critical Care Medicine. Am. J. Respir. Crit. Care Med. 2012; 185:1117-1124.

110. Freed JK, Gutterman DD. Mitochondrial reactive oxygen species and vascular function: less is more. Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):673-5.

111. Patel VK, Naik SK, Naidich DP, Travis WD, Weingarten JA, Lazzaro R, Gutterman DD, Wentowski C, Grosu HB, Raoof S. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm. Chest. 2013 Mar;143(3):840-846.

112. Patel VK, Naik SK, Naidich DP, Travis WD, Weingarten JA, Lazzaro R, Gutterman DD, Wentowski C, Grosu HB, Raoof S. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest. 2013 Mar;143(3):825-839.

113. Durand MJ, Gutterman DD. Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirculation. 2013 Apr;20(3):239-47. PMCID: PMC3625248

114. Ohta M, Toyama K, Gutterman DD, Campbell WB, Lemaître V, Teraoka R, Miura H. Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):629-36. PMCID: PMC3587694

115. Franco DA, Truran S, Burciu C, Gutterman DD, Maltagliati A, Weissig V, Hari P, Migrino RQ. Protective role of clusterin in preserving endothelial function in AL amyloidosis. Atherosclerosis. 2012 Nov;225(1):220-3. PMCID: PMC3478430

116. Kizhakekuttu TJ, Wang J, Dharmashankar K, Ying R, Gutterman DD, Vita JA, Widlansky ME. Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2531-9. PMCID: PMC3570053

117. Bi D, Toyama K, Lemaître V, Takai J, Fan F, Jenkins DP, Wulff H, Gutterman DD, Park F, Miura H. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. J Biol Chem. 2013 May 31;288(22):15843-53. PMCID: PMC3668741

118. Peng Y, Yu D, Gregorich Z, Chen X, Beyer AM, Gutterman DD, Ge Y. In-depth proteomic analysis of human tropomyosin by top-down mass spectrometry. J Muscle Res Cell Motil. 2013 Aug;34(3-4):199-210. PMCID: PMC3849107

119. Rubenstein JC, Gutterman DD. A new application for CPAP in preventing atrial fibrillation. Chest. 2013 May;143(5):1198-1199.

120. Zheng X, Zinkevich NS, Gebremedhin D, Gauthier KM, Nishijima Y, Fang J, Wilcox DA, Campbell WB, Gutterman DD, Zhang DX. Arachidonic acid-induced dilation in human coronary arterioles: convergence of signaling mechanisms on endothelial TRPV4-mediated Ca2+ entry. J Am Heart Assoc. 2013 Apr 25;2(3):e000080. PMCID: PMC3698766

121. Hoch AZ, Pajewski NM, Hoffmann RG, Schimke JE, Gutterman DD. Possible relationship of folic Acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women. J Sports Sci Med. 2009;8(1):123-9. PMCID: PMC3737801

122. Gutterman DD, Durand MJ. Vascular dysfunction in diabetes mellitus: large conductance calcium-activated potassium channels as part of a subsarcolemmal signaling soiree. Circ Res. 2014 Feb 14;114(4):588-90.

123. Carbone RG, Algahim MF, Rizzo S, Monselise A, Dart RA, Almassi GH, Gutterman DD. Cardiovascular risk in patients without known cardiovascular disease. Eur Rev Med Pharmacol Sci. 2014;18(3):365-73.

124. Freed JK, Beyer AM, LoGiudice JA, Hockenberry JC, Gutterman DD. Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation. Circ Res. 2014 Aug 15;115(5):525-32. PMCID: PMC4640193

125. Durand MJ, Gutterman DD. Exercise and vascular function: how much is too much? Can J Physiol Pharmacol. 2014 Jul;92(7):551-7. PMCID: PMC4398063

126. Durand MJ, Phillips SA, Widlansky ME, Otterson MF, Gutterman DD. The vascular renin-angiotensin system contributes to blunted vasodilation induced by transient high pressure in human adipose microvessels. Am J Physiol Heart Circ Physiol. 2014 Jul 01;307(1):H25-32. PMCID: PMC4080172

127. Beyer AM, Durand MJ, Hockenberry J, Gamblin TC, Phillips SA, Gutterman DD. An acute rise in intraluminal pressure shifts the mediator of flow-mediated dilation from nitric oxide to hydrogen peroxide in human arterioles. Am J Physiol Heart Circ Physiol. 2014 Dec 01;307(11):H1587-93. PMCID: PMC4255007

128. Durand MJ, Dharmashankar K, Bian JT, Das E, Vidovich M, Gutterman DD, Phillips SA. Acute exertion elicits a H2O2-dependent vasodilator mechanism in the microvasculature of exercise-trained but not sedentary adults. Hypertension. 2015 Jan;65(1):140-5. PMCID: PMC4268168

129. Lebovitz HE, Ludvik B, Yaniv I, Schwartz T, Zelewski M, Gutterman DD, Metacure Investigators. Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years. Horm Metab Res. 2015 Jun;47(6):456-62.

130. Beyer AM, Freed JK, Durand MJ, Riedel M, Ait-Aissa K, Green P, Hockenberry JC, Morgan RG, Donato AJ, Peleg R, Gasparri M, Rokkas CK, Santos JH, Priel E, Gutterman DD. Critical Role for Telomerase in the Mechanism of Flow-Mediated Dilation in the Human Microcirculation. Circ Res. 2016 Mar 04;118(5):856-66. PMCID: PMC4772813

131. Durand MJ, Murphy SA, Schaefer KK, Hunter SK, Schmit BD, Gutterman DD, Hyngstrom AS. Impaired Hyperemic Response to Exercise Post Stroke. PLoS One. 2015;10(12):e0144023. PMCID: PMC4667998

132. Ellinsworth DC, Sandow SL, Shukla N, Liu Y, Jeremy JY, Gutterman DD. Endothelium-Derived Hyperpolarization and Coronary Vasodilation: Diverse and Integrated Roles of Epoxyeicosatrienoic Acids, Hydrogen Peroxide, and Gap Junctions. Microcirculation. 2016 Jan;23(1):15-32. PMCID: PMC4707990

133. Gutterman DD, Chabowski DS, Kadlec AO, Durand MJ, Freed JK, Ait-Aissa K, Beyer AM. The Human Microcirculation: Regulation of Flow and Beyond. Circ Res. 2016 Jan 08;118(1):157-72. PMCID: PMC4742348

134. Kadlec AO, Beyer AM, Ait-Aissa K, Gutterman DD. Mitochondrial signaling in the vascular endothelium: beyond reactive oxygen species. Basic Res Cardiol. 2016 May;111(3):26. PMCID: PMC6749826

135. Durand MJ, Zinkevich NS, Riedel M, Gutterman DD, Nasci VL, Salato VK, Hijjawi JB, Reuben CF, North PE, Beyer AM. Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase. Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1254-62. PMCID: PMC4882242

136. Kadlec AO, Chabowski DS, Ait-Aissa K, Gutterman DD. Role of PGC-1α in Vascular Regulation: Implications for Atherosclerosis. Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1467-74. PMCID: PMC4965312

137. Durand MJ, Buchanan CE, Hoch AZ, Gutterman DD. Does Barostress On The Endothelium During Maximal Exertion Cause Endothelial Dysfunction In Healthy, Sedentary Subjects?: 707 Board #23 June 1, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc. 2016 May;48(5 Suppl 1):189-90.

138. Levi-Rosenzvig R, Beyer AM, Hockenberry J, Ben-Shushan RS, Chuyun D, Atiya S, Tamir S, Gutterman DD, Szuchman-Sapir A. 5,6-δ-DHTL, a stable metabolite of arachidonic acid, is a potential EDHF that mediates microvascular dilation. Free Radic Biol Med. 2017 Feb;103:87-94.

139. Beyer AM, Zinkevich N, Miller B, Liu Y, Wittenburg AL, Mitchell M, Galdieri R, Sorokin A, Gutterman DD. Transition in the mechanism of flow-mediated dilation with aging and development of coronary artery disease. Basic Res Cardiol. 2017 Jan;112(1):5. PMCID: PMC6758541

140. Yang L, Cheriyan J, Gutterman DD, Mayer RJ, Ament Z, Griffin JL, Lazaar AL, Newby DE, Tal-Singer R, Wilkinson IB. Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers. Chest. 2017 Mar;151(3):555-563. PMCID: PMC5332206

141. Nishijima Y, Cao S, Chabowski DS, Korishettar A, Ge A, Zheng X, Sparapani R, Gutterman DD, Zhang DX. Contribution of K_V1.5 Channel to Hydrogen Peroxide-Induced Human Arteriolar Dilation and Its Modulation by Coronary Artery Disease. Circ Res. 2017 Feb 17;120(4):658-669. PMCID: PMC5315616

142. Buchanan CE, Kadlec AO, Hoch AZ, Gutterman DD, Durand MJ. Hypertension during Weight Lifting Reduces Flow-Mediated Dilation in Nonathletes. Med Sci Sports Exerc. 2017 Apr;49(4):669-675. PMCID: PMC5357152

143. Somberg LB, Gutterman DD, Miura H, Nirula R, Hatoum OA. Shock associated with endothelial dysfunction in omental microvessels. Eur J Clin Invest. 2017 Jan;47(1):30-37.

144. Kadlec AO, Chabowski DS, Ait-Aissa K, Hockenberry JC, Otterson MF, Durand MJ, Freed JK, Beyer AM, Gutterman DD. PGC-1α (Peroxisome Proliferator-Activated Receptor γ Coactivator 1-α) Overexpression in Coronary Artery Disease Recruits NO and Hydrogen Peroxide During Flow-Mediated Dilation and Protects Against Increased Intraluminal Pressure. Hypertension. 2017 Jul;70(1):166-173. PMCID: PMC5485836

145. Freed JK, Gutterman DD. Communication Is Key: Mechanisms of Intercellular Signaling in Vasodilation. J Cardiovasc Pharmacol. 2017 May;69(5):264-272. PMCID: PMC5424612

146. Zinkevich NS, Fancher IS, Gutterman DD, Phillips SA. Roles of NADPH oxidase and mitochondria in flow-induced vasodilation of human adipose arterioles: ROS-induced ROS release in coronary artery disease. Microcirculation. 2017 Aug;24(6). PMCID: PMC5546408

147. Durand MJ, Ait-Aissa K, Gutterman DD. Regenerative Angiogenesis: Quality Over Quantity. Circ Res. 2017 Apr 28;120(9):1379-1380.

148. Freed JK, Durand MJ, Hoffmann BR, Densmore JC, Greene AS, Gutterman DD. Mitochondria-regulated formation of endothelium-derived extracellular vesicles shifts the mediator of flow-induced vasodilation. Am J Physiol Heart Circ Physiol. 2017 May 01;312(5):H1096-H1104. PMCID: PMC5451582

149. Durand MJ, Ait-Aissa K, Levchenko V, Staruschenko A, Gutterman DD, Beyer AM. Visualization and quantification of mitochondrial structure in the endothelium of intact arteries. Cardiovasc Res. 2019 Aug 01;115(10):1546-1556. PMCID: PMC6648341

150. Allaqaband H, Gutterman DD, Kadlec AO. Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease. Physiology (Bethesda). 2018 Sep 01;33(5):338-347. PMCID: PMC6230549

151. Das EK, Lai PY, Robinson AT, Pleuss J, Ali MM, Haus JM, Gutterman DD, Phillips SA. Regular Aerobic, Resistance, and Cross-Training Exercise Prevents Reduced Vascular Function Following a High Sugar or High Fat Mixed Meal in Young Healthy Adults. Front Physiol. 2018;9:183. PMCID: PMC5853082

152. Ait-Aissa K, Kadlec AO, Hockenberry J, Gutterman DD, Beyer AM. Telomerase reverse transcriptase protects against angiotensin II-induced microvascular endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2018 May 01;314(5):H1053-H1060. PMCID: PMC6008150

153. Chabowski DS, Kadlec AO, Ait-Aissa K, Hockenberry JC, Pearson PJ, Beyer AM, Gutterman DD. Lysophosphatidic acid acts on LPA₁ receptor to increase H₂ O₂ during flow-induced dilation in human adipose arterioles. Br J Pharmacol. 2018 Nov;175(22):4266-4280. PMCID: PMC6193883

154. Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuß G. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. JACC Heart Fail. 2018 Oct;6(10):874-883.

155. Hyngstrom AS, Murphy SA, Nguyen J, Schmit BD, Negro F, Gutterman DD, Durand MJ. Ischemic conditioning increases strength and volitional activation of paretic muscle in chronic stroke: a pilot study. J Appl Physiol (1985). 2018 May 01;124(5):1140-1147. PMCID: PMC6050199

156. Kadlec AO, Gutterman DD. The Yin and Yang of endothelium-derived vasodilator factors. Am J Physiol Heart Circ Physiol. 2018 May 01;314(5):H892-H894. PMCID: PMC6008146

157. Nishijima Y, Korishettar A, Chabowski DS, Cao S, Zheng X, Gutterman DD, Zhang DX. Shaker-related voltage-gated K⁺ channel expression and vasomotor function in human coronary resistance arteries. Microcirculation. 2018 Jan;25(1). PMCID: PMC5760438

158. Kadlec AO, Barnes C, Durand MJ, Gutterman DD. Microvascular Adaptations to Exercise: Protective Effect of PGC-1 Alpha. Am J Hypertens. 2018 Jan 12;31(2):240-246. PMCID: PMC5861535

159. Grosman-Rimon L, Wright E, Freedman D, Kachel E, Hui S, Epstein I, Gutterman D, Eilat-Adar S. Can improvement in hormonal and energy balance reverse cardiovascular risk factors in athletes with amenorrhea? Am J Physiol Heart Circ Physiol. 2019 Sep 01;317(3):H487-H495.

160. Ait-Aissa K, Blaszak SC, Beutner G, Tsaih SW, Morgan G, Santos JH, Flister MJ, Joyce DL, Camara AKS, Gutterman DD, Donato AJ, Porter GA Jr, Beyer AM. Mitochondrial Oxidative Phosphorylation defect in the Heart of Subjects with Coronary Artery Disease. Sci Rep. 2019 May 20;9(1):7623. PMCID: PMC6527853

161. Mahmoud AM, Hwang CL, Szczurek MR, Bian JT, Ranieri C, Gutterman DD, Phillips SA. Low-Fat Diet Designed for Weight Loss But Not Weight Maintenance Improves Nitric Oxide-Dependent Arteriolar Vasodilation in Obese Adults. Nutrients. 2019 Jun 14;11(6). PMCID: PMC6627594

162. Anker SD, Borggrefe M, Neuser H, Ohlow MA, Röger S, Goette A, Remppis BA, Kuck KH, Najarian KB, Gutterman DD, Rousso B, Burkhoff D, Hasenfuss G. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction. Eur J Heart Fail. 2019 Sep;21(9):1103-1113.

163. Durand MJ, Boerger TF, Nguyen JN, Alqahtani SZ, Wright MT, Schmit BD, Gutterman DD, Hyngstrom AS. Two weeks of ischemic conditioning improves walking speed and reduces neuromuscular fatigability in chronic stroke survivors. J Appl Physiol (1985). 2019 Mar 01;126(3):755-763. PMCID: PMC6459385

164. Wenceslau CF, McCarthy CG, Earley S, England SK, Filosa JA, Goulopoulou S, Gutterman DD, Isakson BE, Kanagy NL, Martinez-Lemus LA, Sonkusare SK, Thakore P, Trask AJ, Watts SW, Webb RC. Reply to Boedtkjer and Aalkjaer. Am J Physiol Heart Circ Physiol. 2022 Apr 01;322(4):H687-H688. PMCID: PMC8957339

165. Wenceslau CF, McCarthy CG, Earley S, England SK, Filosa JA, Goulopoulou S, Gutterman DD, Isakson BE, Kanagy NL, Martinez-Lemus LA, Sonkusare SK, Thakore P, Trask AJ, Watts SW, Webb RC. Reply to De Mey et al. Am J Physiol Heart Circ Physiol. 2022 Apr 01;322(4):H683-H684. PMCID: PMC8957323

166. Terwoord JD, Beyer AM, Gutterman DD. Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacol Ther. 2022 Sep;237:108116. PMCID: PMC9294076

167. Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular Dysfunction in Preeclampsia. Cells. 2021 Nov 06;10(11). PMCID: PMC8616535

168. Nishijima Y, Hader SN, Hanson AJ, Zhang DX, Sparapani R, Gutterman DD, Beyer AM. Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2. Cardiovasc Res. 2022 Jan 07;118(1):18-19. PMCID: PMC8689948

169. Aufderheide TP, Engel TW 2nd, Saleh HO, Gutterman DD, Weston BW, Pepe PE, Baker JE, Labinski J, Debaty G, Tang L, Szabo A, Kalra R, Yannopoulos D, Colella MR. Change in out-of-hospital 12-lead ECG diagnostic classification following resuscitation from cardiac arrest. Resuscitation. 2021 Dec;169:45-52.

170. Brandt L, Terwoord JD, Beyer AM, Gutterman DD. Pulling back the curtain on anthracycline cardiotoxicity: the hidden role of the microcirculation. Cardiovasc Res. 2022 Jan 29;118(2):347-349.

171. Wenceslau CF, McCarthy CG, Earley S, England SK, Filosa JA, Goulopoulou S, Gutterman DD, Isakson BE, Kanagy NL, Martinez-Lemus LA, Sonkusare SK, Thakore P, Trask AJ, Watts SW, Webb RC. Guidelines for the measurement of vascular function and structure in isolated arteries and veins. Am J Physiol Heart Circ Physiol. 2021 Jul 01;321(1):H77-H111. PMCID: PMC8321813

172. Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, Álvarez ÉMC, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Autelli R, Avagliano L, Ávalos Y, Aveic S, Aveleira CA, Avin-Wittenberg T, Aydin Y, Ayton S, Ayyadevara S, Azzopardi M, Baba M, Backer JM, Backues SK, Bae DH, Bae ON, Bae SH, Baehrecke EH, Baek A, Baek SH, Baek SH, Bagetta G, Bagniewska-Zadworna A, Bai H, Bai J, Bai X, Bai Y, Bairagi N, Baksi S, Balbi T, Baldari CT, Balduini W, Ballabio A, Ballester M, Balazadeh S, Balzan R, Bandopadhyay R, Banerjee S, Banerjee S, Bánréti Á, Bao Y, Baptista MS, Baracca A, Barbati C, Bargiela A, Barilà D, Barlow PG, Barmada SJ, Barreiro E, Barreto GE, Bartek J, Bartel B, Bartolome A, Barve GR, Basagoudanavar SH, Bassham DC, Bast RC Jr, Basu A, Batoko H, Batten I, Baulieu EE, Baumgarner BL, Bayry J, Beale R, Beau I, Beaumatin F, Bechara LRG, Beck GR Jr, Beers MF, Begun J, Behrends C, Behrens GMN, Bei R, Bejarano E, Bel S, Behl C, Belaid A, Belgareh-Touzé N, Bellarosa C, Belleudi F, Belló Pérez M, Bello-Morales R, Beltran JSO, Beltran S, Benbrook DM, Bendorius M, Benitez BA, Benito-Cuesta I, Bensalem J, Berchtold MW, Berezowska S, Bergamaschi D, Bergami M, Bergmann A, Berliocchi L, Berlioz-Torrent C, Bernard A, Berthoux L, Besirli CG, Besteiro S, Betin VM, Beyaert R, Bezbradica JS, Bhaskar K, Bhatia-Kissova I, Bhattacharya R, Bhattacharya S, Bhattacharyya S, Bhuiyan MS, Bhutia SK, Bi L, Bi X, Biden TJ, Bijian K, Billes VA, Binart N, Bincoletto C, Birgisdottir AB, Bjorkoy G, Blanco G, Blas-Garcia A, Blasiak J, Blomgran R, Blomgren K, Blum JS, Boada-Romero E, Boban M, Boesze-Battaglia K, Boeuf P, Boland B, Bomont P, Bonaldo P, Bonam SR, Bonfili L, Bonifacino JS, Boone BA, Bootman MD, Bordi M, Borner C, Bornhauser BC, Borthakur G, Bosch J, Bose S, Botana LM, Botas J, Boulanger CM, Boulton ME, Bourdenx M, Bourgeois B, Bourke NM, Bousquet G, Boya P, Bozhkov PV, Bozi LHM. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹. Autophagy. 2021 Jan;17(1):1-382. PMCID: PMC7996087

173. Hughes WE, Zinkevich N, Gutterman DD, Beyer AM. Hypertension preserves the magnitude of microvascular flow-mediated dilation following transient elevation in intraluminal pressure. Physiol Rep. 2021 Feb;9(3):e14507. PMCID: PMC7883808

174. Hughes WE, Chabowski DS, Ait-Aissa K, Fetterman JL, Hockenberry J, Beyer AM, Gutterman DD. Critical Interaction Between Telomerase and Autophagy in Mediating Flow-Induced Human Arteriolar Vasodilation. Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):446-457. PMCID: PMC7770118

175. Hyngstrom AS, Nguyen JN, Wright MT, Tarima SS, Schmit BD, Gutterman DD, Durand MJ. Two weeks of remote ischemic conditioning improves brachial artery flow mediated dilation in chronic stroke survivors. J Appl Physiol (1985). 2020 Dec 01;129(6):1348-1354. PMCID: PMC7792845

176. Katunaric B, Cohen KE, Beyer AM, Gutterman DD, Freed JK. Sweat the small stuff: The human microvasculature and heart disease. Microcirculation. 2021 Apr;28(3):e12658. PMCID: PMC7960576

177. Hughes WE, Beyer AM, Gutterman DD. Vascular autophagy in health and disease. Basic Res Cardiol. 2020 Jun 06;115(4):41. PMCID: PMC12306491

178. Chabowski DS, Cohen KE, Abu-Hatoum O, Gutterman DD, Freed JK. Crossing signals: bioactive lipids in the microvasculature. Am J Physiol Heart Circ Physiol. 2020 May 01;318(5):H1185-H1197. PMCID: PMC7541955

179. Kadlec AO, Gutterman DD. Redox Regulation of the Microcirculation. Compr Physiol. 2019 Dec 18;10(1):229-259.

180. Zhang DX, Gutterman DD. Myocardin and Kv1 Channels: A Paradigm Shift in Treating Vascular Smooth Muscle Cell-Related Proliferative Disease? Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):2454-2456. PMCID: PMC6980742

181. Schulz ME, Katunaric B, Hockenberry JC, Gutterman DD, Freed JK. Manipulation of the Sphingolipid Rheostat Influences the Mediator of Flow-Induced Dilation in the Human Microvasculature. J Am Heart Assoc. 2019 Sep 03;8(17):e013153. PMCID: PMC6755855

182. Hader SN, Zinkevich N, Norwood Toro LE, Kriegel AJ, Kong A, Freed JK, Gutterman DD, Beyer AM. Detrimental effects of chemotherapy on human coronary microvascular function. Am J Physiol Heart Circ Physiol. 2019 Oct 01;317(4):H705-H710. PMCID: PMC6843017

183. Hughes WE, Hader SN, Astbury K, Brandt L, Ait-Aissa K, Gutterman DD, Beyer AM. Autophagy modulates the mechanism of flow-mediated dilation upstream of telomerase. Basic Res Cardiol. 2025 Dec;120(6):1131-1140. PMCID: PMC12680695

184. Terwoord JD, Norwood Toro LE, Hader SN, Hammond ST, Hockenberry JC, Linn J, Vazirabad IY, Kong AL, Kriegel AJ, Liu Z, Kivelä RM, Murtagh G, Gutterman DD, Beyer AM. Characterization of anticancer therapy-induced microvascular dysfunction in patients with breast cancer supports targeted intervention. JCI Insight. 2025 Nov 24;10(22). PMCID: PMC12643535

185. Naas CJ, Saleh HO, Engel TW 2nd, Gutterman DD, Szabo A, Grawey T, Weston BW, Monti CE, Baker JE, Labinski J, Tang L, Jasti J, Bartos JA, Kalra R, Yannopoulos D, Riccardo Colella M, Aufderheide TP. Associations with resolution of ST-segment elevation myocardial infarction criteria on out-of-hospital 12-lead electrocardiograms following resuscitation from cardiac arrest. Resuscitation. 2025 Apr;209:110567.

186. Hyngstrom AS, Nguyen JN, Gutterman DD, Schmit BD, Klevenow EA, Durand MJ. Noninvasive estimation of skeletal muscle oxygen consumption rate and microvascular reactivity in chronic stroke survivors using near-infrared spectroscopy. J Appl Physiol (1985). 2024 Jul 01;137(1):23-31. PMCID: PMC11389892

187. Hyngstrom AS, Nguyen JN, Murphy SA, Raab SC, Schmit BD, Gutterman DD, Durand MJ. Reduced oxygen desaturation in the vastus lateralis of chronic stroke survivors during graded muscle contractions. Top Stroke Rehabil. 2024 Jul;31(5):513-526. PMCID: PMC11129930

188. Asulin M, Gorodetzer N, Fridman R, Shelly Ben-Shushan R, Cohen Z, Beyer AM, Chuyun D, Gutterman DD, Szuchman-Sapir A. 5,6-diHETE lactone (EPA-L) mediates hypertensive microvascular dilation by activating the endothelial GPR-PLC-IP₃ signaling pathway. Biochem Biophys Res Commun. 2024 Mar 12;700:149585.

189. Hyngstrom AS, Nguyen JN, Uhrich TD, Wright MT, Gutterman DD, Schmit BD, Durand MJ. Quantification of Tissue Oxygen Saturation in the Vastus Lateralis Muscle of Chronic Stroke Survivors during a Graded Exercise Test. Cardiopulm Phys Ther J. 2023 Jan;34(1):39-50. PMCID: PMC9937433

190. SenthilKumar G, Mathieu NM, Freed JK, Sigmund CD, Gutterman DD. Addressing the decline in graduate students' mental well-being. Am J Physiol Heart Circ Physiol. 2023 Oct 01;325(4):H882-H887.

191. McIntosh JJ, Gutterman DD. Two Strikes and You Are Out: Long-Term Cardiovascular Consequences of the Additive Effects of Pregnancy and a Brief High-Cholesterol Diet. Arterioscler Thromb Vasc Biol. 2023 Jan;43(1):133-135. PMCID: PMC9780173

192. Kuprian N, Aafjes-van Doorn K, Gutterman D, Barber JP. Therapeutic immediacy in psychodynamic psychotherapy for depression: A mixed-method study. Psychotherapy (Chic). 2022 Dec;59(4):554-566.

193. Grosman-Rimon L, Wright E, Sabovich S, Rimon J, Gleitman S, Sudarsky D, Lubovich A, Gabizon I, Lalonde SD, Tsuk S, McDonald MA, Rao V, Gutterman D, Jorde UP, Carasso S, Kachel E. Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients. Heart Fail Rev. 2023 Jan;28(1):35-45.

194. Nowroozpoor A, Gutterman D, Safdar B. Is microvascular dysfunction a systemic disorder with common biomarkers found in the heart, brain, and kidneys? - A scoping review. Microvasc Res. 2021 Mar;134:104123.

195. Bodker A, Visotcky A, Gutterman D, Widlansky ME, Kulinski J. The impact of standing desks on cardiometabolic and vascular health. Vasc Med. 2021 Aug;26(4):374-382. PMCID: PMC9578685

196. Berger MG, Gutterman D. Risk-Based Disease Surveillance: The Promise of Early Atrial Fibrillation Identification. Chest. 2019 Mar;155(3):458-459. PMCID: PMC6435909

197. Irwin RS, Heffner JE, Maxwell L, French CL, Augustyn N, Frantsve-Hawley J, Editorial Leadership Team(∗). Spread the Word About CHEST in 2019: Innovations, Introductions, and Farewells. Chest. 2019 Jan;155(1):1-4.

198. Sparapani R, Dabbouseh NM, Gutterman D, Zhang J, Chen H, Bluemke DA, Lima JAC, Burke GL, Soliman EZ. Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA. J Am Heart Assoc. 2019 Mar 05;8(5):e009959. PMCID: PMC6474924

199. Kuschyk J, Nägele H, Heinz-Kuck K, Butter C, Lawo T, Wietholt D, Roeger S, Gutterman D, Burkhoff D, Rousso B, Borggrefe M. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT). Int J Cardiol. 2019 Feb 15;277:173-177.

200. Chabowski D, Kadlec A, Dellostritto D, Gutterman D. Adapt or Perish: Updating the Predoctoral Training Model. Circ Res. 2017 Mar 31;120(7):1081-1083. PMCID: PMC5380225

201. Zucker IH, Lindsey ML, Delmar M, De Windt LJ, Des Rosiers C, Diz DI, Hester RL, Jones SP, Kanagy NL, Kitakaze M, Liao R, Lopaschuk GD, Patel KP, Recchia FA, Sadoshima J, Shah AM, Ungvari Z, Benjamin IJ, Blaustein MP, Charkoudian N, Efimov IR, Gutterman D, Kass DA, Liao Y, O'Leary DS, Ripplinger CM, Wolin MS. Why publish in the <i>American Journal of Physiology-Heart and Circulatory Physiology</i>? Am J Physiol Heart Circ Physiol. 2017 Aug 01;313(2):H221-H223.

202. Müller D, Remppis A, Schauerte P, Schmidt-Schweda S, Burkhoff D, Rousso B, Gutterman D, Senges J, Hindricks G, Kuck KH. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction. Clin Res Cardiol. 2017 Nov;106(11):893-904. PMCID: PMC5655601

203. Abi-Samra F, Gutterman D. Cardiac contractility modulation: a novel approach for the treatment of heart failure. Heart Fail Rev. 2016 Nov;21(6):645-660. PMCID: PMC5082590

204. Röger S, Said S, Kloppe A, Lawo T, Emig U, Rousso B, Gutterman D, Borggrefe M, Kuschyk J. Cardiac contractility modulation in heart failure patients: Randomized comparison of signal delivery through one vs. two ventricular leads. J Cardiol. 2017 Jan;69(1):326-332.

205. Liu M, Fang F, Luo XX, Shlomo BH, Burkhoff D, Chan JY, Chan CP, Cheung L, Rousso B, Gutterman D, Yu CM. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study. Int J Cardiol. 2016 Mar 01;206:122-6.

206. Tschöpe C, Van Linthout S, Spillmann F, Klein O, Biewener S, Remppis A, Gutterman D, Linke WA, Pieske B, Hamdani N, Roser M. Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF. Int J Cardiol. 2016 Jan 15;203:1061-6.

207. Chabowski D, Gutterman D. Unveiling the Mechanism of Coronary Metabolic Vasodilation: Voltage-Gated Potassium Channels and Hydrogen Peroxide. Circ Res. 2015 Sep 11;117(7):589-91. PMCID: PMC4574506

208. Irwin RS, Welch SJ, Rice J, French CT, Editorial Leadership Team. Spread the Word About CHEST in 2015: Rising Impact Factor, Continuous Innovations, and Changes to the Editorial Team. Chest. 2015 Jan;147(1):1-3.

209. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess DR, Hill NS, Horan T, Kollef M, Levy M, Septimus E, Vanantwerpen C, Wright D, Lipsett P. Executive summary: Developing a new, national approach to surveillance for ventilator-associated events. Ann Am Thorac Soc. 2013 Dec;10(6):S220-3.

210. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess D, Hill NS, Horan T, Kollef M, Levy M, Septimus E, Vanantwerpen C, Wright D, Lipsett P. Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Clin Infect Dis. 2013 Dec;57(12):1742-6. PMCID: PMC3840402

211. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess DR, Hill NS, Horan T, Kollef M, Levy M, Septimus E, Vanantwerpen C, Wright D, Lipsett P. Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Infect Control Hosp Epidemiol. 2013 Dec;34(12):1239-43.

212. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess DR, Hill NS, Horan T, Kollef M, Levy M, Septimus E, VanAntwerpen C, Wright D, Lipsett P. Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Chest. 2013 Nov;144(5):1448-1452. PMCID: PMC5831651

213. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess DR, Hill NS, Horan T, Kollef M, Levy M, Septimus E, Vanantwerpen C, Wright D, Lipsett P. Developing a new, national approach to surveillance for ventilator-associated events. Am J Crit Care. 2013 Nov;22(6):469-73.

214. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess DR, Hill NS, Horan T, Kollef M, Levy M, Septimus E, VanAntwerpen C, Wright D, Lipsett P. Developing a new national approach to surveillance for ventilator-associated events: executive summary. Am J Infect Control. 2013 Nov;41(11):1096-9.

215. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess DR, Hill NS, Horan T, Kollef M, Levy M, Septimus E, VanAntwerpen C, Wright D, Lipsett P. Developing a new, national approach to surveillance for ventilator-associated events: Executive summary Respiratory Care. 1 November 2013;58(11):1985-1989.

216. Magill SS, Klompas M, Balk R, Burns SM, Deutschman CS, Diekema D, Fridkin S, Greene L, Guh A, Gutterman D, Hammer B, Henderson D, Hess D, Hill NS, Horan T, Kollef M, Levy M, Septimus E, VanAntwerpen C, Wright D, Lipsett P. Developing a new, national approach to surveillance for ventilator-associated events*. Crit Care Med. 2013 Nov;41(11):2467-75. PMCID: PMC10847970

217. Guyatt G, Eikelboom JW, Akl EA, Crowther M, Gutterman D, Kahn SR, Schunemann H, Hirsh J. A guide to GRADE guidelines for the readers of JTH. J Thromb Haemost. 2013 Aug;11(8):1603-8.

218. Guyatt G, Akl EA, Oxman A, Wilson K, Puhan MA, Wilt T, Gutterman D, Woodhead M, Antman EM, Schünemann HJ, ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development. Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012 Dec;9(5):256-61.

219. Guntupalli KK, Gutterman D, Raoof S, Markowski PA. Response Chest. 1 June 2011;139(6):1550.

220. Guntupalli KK, Gutterman D, Raoof S, Markowski PA. 2010: the year of the lung. Chest. 2010 Dec;138(6):1287-8. PMCID: PMC7130325

221. Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, Lewis SZ, Nathanson I, Jaeschke R, Schünemann H. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. 2010 Jun 01;152(11):738-41.

222. Hoch AZ, Pajewski NM, Hoffmann RG, Schimke JE, Gutterman DD. Possible relationship of folic acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women Journal of Sports Science and Medicine. March 2009;8(1):123-129.

223. Liu Y, Frisbee JC, Gutterman DD. Reactive oxygen species and K⁺ channel function in diabetes and insulin resistance Diabetes Mellitus Research Advances. February 2009:63-98.

224. Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):670S-707S.

225. Baumann MH, Lewis SZ, Gutterman D, American College of Chest Physicians. ACCP evidence-based guideline development: a successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations. Chest. 2007 Sep;132(3):1015-24.

226. Mayr M, Zhang J, Greene AS, Gutterman D, Perloff J, Ping P. Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights. Mol Cell Proteomics. 2006 Oct;5(10):1853-64.

227. Guyatt G, Baumann M, Pauker S, Halperin J, Maurer J, Owens DK, Tosteson AN, Carlin B, Gutterman D, Prins M, Lewis SZ, Schünemann H. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest. 2006 Jan;129(1):182-7.

228. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schünemann H. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest. 2006 Jan;129(1):174-81.

229. McKeown PP, Gutterman D, American College of Chest Physicians. Executive summary: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005 Aug;128(2 Suppl):1S-5S.

230. Slyper A, Le A, Jurva J, Gutterman D. The influence of lipoproteins on whole-blood viscosity at multiple shear rates. Metabolism. 2005 Jun;54(6):764-8.

231. Slyper A, Jurva J, Pleuss J, Hoffmann R, Gutterman D. Influence of glycemic load on HDL cholesterol in youth. Am J Clin Nutr. 2005 Feb;81(2):376-9.

232. Wilcox CS, Gutterman D. Focus on oxidative stress in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H3-6.

233. Stein PD, Schünemann HJ, Dalen JE, Gutterman D. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):600S-608S.

234. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, Loyd JE, American College of Chest Physicians. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul;126(1 Suppl):14S-34S.

235. Kalyanaraman B, Gutterman DD. Prologue: Vascular effects of free radicals American Journal of Physiology - Heart and Circulatory Physiology. December 2003;285(6 54-6).

236. Gutterman DD, Hume J. Potassium channels that regulate vascular tone: Which are the important players? Clinical and Experimental Pharmacology and Physiology. 2002;29(4):304.

237. Miura H, Wachtel RE, Liu Y, Loberiza FR, Saito T, Miura M, Gutterman DD. Flow-induced dilation of human coronary arterioles important role of Ca²⁺-activated K⁺ channels Circulation. 17 April 2001;103(15):1992-1998.

238. Welch KM, Mathew NT, Stone P, Rosamond W, Saiers J, Gutterman D. Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia. 2000 Oct;20(8):687-95.

239. Bahtiyar G, Gutterman D, Lebovitz H. Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus. Curr Diab Rep. 2016 Nov;16(11):116. PMCID: PMC5059411

240. Drachuk K, Nishijima Y, Parthasarathy A, Xie Y, Nagavally S, Dawson A, Gutterman DD, Zhang DX. The role of NO, H₂O₂, and non-NO/H₂O₂ mechanisms in acetylcholine (ACh)-induced dilation of human arterioles in the absence and presence of coronary artery disease. Basic Res Cardiol. 2025 Dec;120(6):1091-1108. PMCID: PMC13046465

241. Do Couto N, Hidde M, Grigoriadis G, Sparapani R, Durand M, Widlansky M, Jankowski C, Berendt M, Canales B, Golus S, Norwood Toro LE, Laud P, Kong A, Hoskins K, Lewandowski D, Phillips SA, Gutterman DD, Kriegel AJ, Beyer KMM, Beyer AM, Stolley M. Take charge during treatment: a protocol for a pilot study to evaluate the impact of exercise on cardiovascular biomarkers among black and white breast cancer patients undergoing treatment. Cardiooncology. 2025 Aug 21;11(1):75. PMCID: PMC12369258

242. Hyngstrom AS, Nguyen JN, Uhrich TD, Wright MT, Gutterman DD, Schmit BD, Durand MJ. Quantification of Tissue Oxygen Saturation in the Vastus Lateralis Muscle of Chronic Stroke Survivors during a Graded Exercise Test Cardiopulmonary Physical Therapy Journal. 1 January 2023;34(1):39-50.

243. Chabowski DS, Hughes WE, Hockenberry JC, LoGiudice J, Beyer AM, Gutterman DD. Lipid phosphate phosphatase 3 maintains NO-mediated flow-mediated dilatation in human adipose resistance arterioles. J Physiol. 2023 Feb;601(3):469-481. PMCID: PMC10979460

244. Ait-Aissa K, Norwood-Toro LE, Terwoord J, Young M, Paniagua LA, Hader SN, Hughes WE, Hockenberry JC, Beare JE, Linn J, Kohmoto T, Kim J, Betts DH, LeBlanc AJ, Gutterman DD, Beyer AM. Noncanonical Role of Telomerase in Regulation of Microvascular Redox Environment With Implications for Coronary Artery Disease. Function (Oxf). 2022;3(5):zqac043. PMCID: PMC9508843

245. Xie Y, Nishijima Y, Zinkevich NS, Korishettar A, Fang J, Mathison AJ, Zimmermann MT, Wilcox DA, Gutterman DD, Shen Y, Zhang DX. NADPH oxidase 4 contributes to TRPV4-mediated endothelium-dependent vasodilation in human arterioles by regulating protein phosphorylation of TRPV4 channels. Basic Res Cardiol. 2022 Apr 25;117(1):24. PMCID: PMC9119129

246. Batra A, Swaby J, Raval P, Zhu H, Weintraub NL, Terris M, Karim NA, Keruakous A, Gutterman D, Beyer K, Stolley M, Brown SA, Guha A. Effect of Community and Socio-Economic Factors on Cardiovascular, Cancer and Cardio-Oncology Patients with COVID-19 Covid. March 2022;2(3):350-368.

247. Nowroozpoor A, Gutterman D, Safdar B. Utility of discovery approach using proteomics to create a biomarker profile for coronary microvascular dysfunction. Microvasc Res. 2020 May;129:103985. PMCID: PMC10291513

248. Mammoto T, Torisawa YS, Muyleart M, Hendee K, Anugwom C, Gutterman D, Mammoto A. Effects of age-dependent changes in cell size on endothelial cell proliferation and senescence through YAP1. Aging (Albany NY). 2019 Sep 05;11(17):7051-7069. PMCID: PMC6756888

249. Murphy S, Durand M, Negro F, Farina D, Hunter S, Schmit B, Gutterman D, Hyngstrom A. The Relationship Between Blood Flow and Motor Unit Firing Rates in Response to Fatiguing Exercise Post-stroke. Front Physiol. 2019;10:545. PMCID: PMC6524339

250. Tschöpe C, Kherad B, Klein O, Lipp A, Blaschke F, Gutterman D, Burkhoff D, Hamdani N, Spillmann F, Van Linthout S. Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond. Eur J Heart Fail. 2019 Jan;21(1):14-22. PMCID: PMC6607484

251. Mammoto A, Muyleart M, Kadlec A, Gutterman D, Mammoto T. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α. Microvasc Res. 2018 Sep;119:73-83. PMCID: PMC6005762

252. Bosetti F, Galis ZS, Bynoe MS, Charette M, Cipolla MJ, Del Zoppo GJ, Gould D, Hatsukami TS, Jones TL, Koenig JI, Lutty GA, Maric-Bilkan C, Stevens T, Tolunay HE, Koroshetz W, “Small Blood Vessels: Big Health Problems” Workshop Participants. "Small Blood Vessels: Big Health Problems?": Scientific Recommendations of the National Institutes of Health Workshop. J Am Heart Assoc. 2016 Nov 04;5(11). PMCID: PMC5210346

253. Miura H, Gutterman DD. Role of CA²⁺-activated potassium channels in human coronary arteriolar relaxation to bradykinin FASEB Journal. 1997;11(3).

254. Murphy SL, Beasley K, Gutterman DD. Circulating factor in diabetic serum contributes to impaired endothelial dependent dilation FASEB Journal. 1997;11(3).

255. Oltman CL, Gutterman DD, Quinn KA, Bar RS, Dellsperger KC. Insulin and IGF-1 induced vasodilation in canine coronary microvessels FASEB Journal. 1997;11(3).

256. Miura H, Charoeu PA, Gutterman DD. PReserved dilation in carotid arteries of apolipoprotein(apo) e and apoe + ldl receptor-deficient mice FASEB Journal. 1996;10(3).

257. Bocker J, Chaooeu PA, Gutterman DD. SElective impairment of endothelium-dependent vasodilation following responses to oxidized low density lipoprotein (ox-ldl) FASEB Journal. 1996;10(3).

258. Ben-Haim SA, Kienzle M, Gutterman D. Beat-by-beat ECG variability for detection of patients with positive electrophysiologic study Journal of Electrocardiology. 1992;25(SUPPL.):159.

259. Gutterman DD, Pardubsky PD, Clothier J, Marcus ML, Brody MJ. Coronary vasoconstriction in response to epicardial hypothermia Coronary Artery Disease. 1991;2(1):75-86.

260. Gutterman DD, Bonham AC, Arthur JM. Coronary vasoconstriction to stimulation in brainstem regions receiving nociceptive afferent input Federation Proceedings. 1985;44(3).

261. Bonham AC, Gutterman DD, Marcus ML. Electrical stimulation in the hypothalamus evokes coronary vasoconstriction Federation Proceedings. 1984;43(3).

262. Gutterman DD, Rusch NJ, Hermsmeyer RK. Differential reactivity of large and small coronary arteries to 5-hydroxytryptamine Federation Proceedings. 1984;43(4).

1. Gutterman DD, Bonham AC, Arthur JA, Gebhart GF, Marcus ML, Brody MJ: Central Neural Regulation of Coronary Blood Flow. In: Brain Peptides and Catecholamines in Cardiovascular Regulation in Normal and Disease States, J.P. Buckley and C.M. Ferrario (Eds.), Raven Press, New York, 1987.

2. Gutterman DD, Marcus ML: Advances in Understanding the Function of the Coronary Circulation in Physiological and Pathological States. In: Advances In Cardiovascular Surgery, Wechsler, A.S. (ed).

3. Gutterman DD, Bonham AC, Stuhlmuller JE, Arthur JM, Gebhart GF, Marcus ML, Brody MJ: Central Neural Aspects of Coronary Flow Regulation. In: Analysis and Simulation of the Cardiac System - Ischemia, Chapter 19, S. Sideman and R. Beyar (eds), CRC Press, Boca Raton, FL, pp. 249-264, 1989.

4. Gutterman DD, Brody MJ, Marcus ML: Neural Reg¬ulation of Coronary Blood Flow. In: Reflex Control of the Circulation, I.H. Zucker and J. Gilmore (eds), Chapter 19, CRC Press, Boca Raton, FL, pp. 695-736, 1991.

5. Gutterman DD: Central Integration of Autonomic Control of the Heart Including the Coronary Circulation. In: Volume IX: The Nervous Control of the Heart. J.T. Shepherd and S.F. Vatner (eds.), Geoffrey Burnstock (Series Ed.), Harwood Acad. Publishers, Amsterdam, pp. 253-294, 1996.

6. Gutterman DD, Schnoll D: Neural Control of the Coronary Circulation. In: Volume VIII: Nervous Control of Blood Vessels. T. Bennett and S. M. Gardiner (eds), Geoffrey Burnstock (Series Ed.), Harwood Acad. Publishers, Amsterdam, pp. 265-304, 1996.

7. Gutterman DD, Liu Y, Frisbee JC: Reactive Oxygen Species and K+ Channel Function in Diabetes and Insulin Resistance. In: Trends in Diabetes Research, Ford, A.(ed), Chapter 4, Nova Science Publishers, Inc., New York, pp. 71-106, 2006.

1. Gutterman DD. Characterization of the acute left ven¬tricular thrombus: hermit or nomad? J Am Coll Cardiol 1989 Mar 1;13(3):565-6.

2. Gutterman DD, Ayres RW. Use of echocardiography in detecting cardiac sources of embolus. Echocardiography 1993 Mar;10(3):311-20.

3. Lindower PD, Gutterman DD. Detection of cardioembolic sources with echocardiography. Compr Ther 1994;20(3):174-80.

4. Gutterman DD. Adventitia-dependent influences on vascular function. Am J Physiol 1999 Oct;277(4 Pt 2):H1265-72.

5. Chilian WM, Gutterman DD. Prologue: new insights into the regulation of the coronary microcirculation. Am J Physiol Heart Circ Physiol 2000 Dec;279(6):H2585-6.

6. Gutterman DD, Hume J. Potassium channels that regulate vascular tone: Which are the important players? Clin Exp Pharm Phys 2002; 29:304.

7. Liu Y, Gutterman DD. Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol 2002 Apr;29(4):305-11.

8. Gutterman DD. Vascular dysfunction in hyperglycemia: is protein kinase C the culprit? Circ Res 2002 Jan 11;90(1):5-7.

9. Liu Y, Gutterman DD. The coronary circulation in diabetes: influence of reactive oxygen species on K+ channel-mediated vasodilation. Vascul Pharmacol 2002 Jan;38(1): 43-9.

10. Konidala S, Gutterman DD. Coronary vasospasm and the regulation of coronary blood flow. Prog Cardiovasc Dis 2004 Jan-Feb;46(4):349-73.

11. Wilcox CS, Gutterman DD. Focus on oxidative stress in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 2005 Jan;288(1):H3-6.

12. Gutterman DD, Miura H, Liu Y. Redox modulation of vascular tone: focus of potassium channel mechanisms of dilation." Arterioscler Thromb Vasc Biol 2005 Apr;25(4):671-8.

13. Gutterman DD. Mitochondria and reactive oxygen species: an evolution in function. Circ Res 2005 Aug 19;97(4):302-4.

14. Hatoum OA, Binion DG, Gutterman DD. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest 2005 Oct;35(10):599-609.

15. Baumann MH, Gutterman DD. American College of Chest Physicians evidence based guidelines--the next generation: considering resource use and evolution to a single grading system. Chest 2006 Jan;129(1):10-2.

16. Irwin RS, Gutterman DD. American College of Chest Physicians cough guidelines. Lancet 2006 Mar 25;367(9515):981.

17. Larsen BT, Gutterman DD, Hatoum OA. Emerging role of epoxyeicosatrienoic acids in coronary vascular function. Eur J Clin Invest. 2006 May;36(5): 293-300.

18. Larsen BT, Gutterman DD. Hypoxia, coronary dilation, and the pentose phosphate pathway. Am J Physiol Heart Circ Physiol 2006 Jun;290(6): H2169-71.

19. Mayr M, Zhang J, Greene AS, Gutterman DD, Perloff J, Ping P. Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights. Mol Cell Proteomics 2006 Oct;5(10):1853-64.

20. Gutterman DD, Cowley AW Jr. Relating cardiac performance with oxygen consumption: historical observations continue to spawn scientific discovery. Am J Physiol Heart Circ Physiol 2006 Dec;291(6):H2555-6.

21. Larsen BT, Campbell WB, Gutterman DD. Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system. Trends Pharmacol Sci 2007 Jan;28(1):32-8.

22. Zhang DX, Gutterman DD. Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol 2007 May;292(5): H2023-31.

23. Hoch AZ, Lal S, Jurva JW, Gutterman DD. The female athlete triad and cardiovascular dysfunction. Phys Med Rehabil Clin N Am 2007 Aug;18(3):385-400, vii-viii.

24. Gutterman DD. Combating nitrate tolerance - A novel endogenous mechanism. Arterioscler Thromb Vasc Biol. 2007 Aug; 27(8):1673-6.

25. Pagano PJ, Gutterman DD. The adventitia: the outs and ins of vascular disease. Cardiovasc Res 2007 Sep 1;75(4):636-9.

26. Larsen BT, Zhang DX, Gutterman DD. Epoxyeicosatrienoic acids, TRP channels, and intracellular Ca2+ in the vasculature: an endothelium-derived endothelium hyperpolarizing factor? Arterioscler Thromb Vasc Biol 2007 Dec;27(12):2496-8.

27. Liu Y, Gutterman DD. Vascular control in humans: focus on the coronary microcirculation. Basic Res Cardiol 2009 Feb 3;104:211-27. PMCID: PMC3045058

28. Gutterman DD. Silent Myocardial Ischemia. Circ J 2009 Apr 24;73(5):785-97.

29. Larsen BT, Gutterman DD. C-reactive protein: A multipronged assailant on endothelium-dependent vasodilation. J Mol Cell Cardiol 2009 Aug;47(2):177-9.

30. Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman DD, Zelman Lewis S, Nathanson I, Jaeschke R, Schunemann H. The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution. Ann Intern Med. 2010 Jun 1;152:738-41.

31. O'Connor PM, Gutterman DD. Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria. Circ Res. 2010 Jul 9;107(1):9-11. PMCID: PMC2929761

32. Guntupalli KK, Gutterman DD, Raoof S, Markowski PA. 2010: The Year of the Lung. Chest December 2010 138:1287-1288.

33. Zhang DX, Gutterman DD. TRP channel activation and endothelium-dependent dilation in the systemic circulation. J Cardiovasc Pharmacol. 2011 Feb;57(2):133-9. PMCID: PMC3047599

34. Widlansky ME, Gutterman DD. Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid Redox Signal. 2011 Sep 15;15(6):1517-30. PMCID: PMC3151425.

35. Zinkevich NS, Gutterman DD. ROS induced ROS release in vascular biology: redox-redox signaling. Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H647-53. PMCID: PMC3191081

36. Beyer A, Gutterman DD. Regulation of the Human Coronary Microcirculation. J Mol Cell Cardiol. 2011 Oct 12. 52:814-821. PMCID: PMC3306504

37. Guyatt GH, Akl EA, Crowther M, Schünemann HJ, Gutterman DD, Zelman Lewis S. Introduction to the Ninth Edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 2012 Feb;14 (2 Suppl):48S-52S. PMC Journal: In Process.

1. Gutterman DD, Chilian WM, Eastham CL, Inou T, Bohling BA, Marcus ML, White CW: Failure of Intracoronary Pyruvate to Salvage Myocardium after Three Hours of Myocardial Ischemia. Fed Proc, 42:1093, 1983.

2. Gutterman DD, Rusch NJ, Hermsmeyer RK, Dole WP: Differential Reactivity of Large and Small Coronary Arteries to 5 Hydroxytryptamine. Fed Proc, 43:3597, 1984.

3. Gutterman DD, Bonham AC, Arthur JM, Gebhart GF, Marcus ML, Brody MJ: Coronary Vasoconstriction to Stimulation in Brainstem Regions Receiving Nociceptive Afferent Input Fed Proc, 44(3):622, 1985.

4. Bonham AC, Arthur GF, Marcus JM, Gebhart ML, Brody MJ. Lateral hypothalamus (LH)-A central site for neurally mediated coronary vasoconstriction.

5. Arthur JM, Bonham AC, Gebhart GF, Marcus ML, Brody MJ. Stimulation in the anteromedial hypothalamus in the area of the paraventricular nucleus produces coronary vasoconstriction.

6. Bonham AC, Wilkin LD, Arthur JM, Gutterman DD, Gebhart GF, Marcus ML, Brody MJ: Brainstem Efferents from a Lateral Hypothalamic Site Which Produces a Decrease in Coronary Blood Flow. The Physiologist, 28(4):275, 1985.

7. Gutterman DD, Gebhart GF, Arthur JM, Bonham AC, Marcus ML, Brody MJ: Frequency-Dependent Selective Activation of Coronary Vasoconstriction by Electrical Stimulation in Brainstem. Clin Res, 33(4):806A, 1985.

8. Gutterman DD, Bonham AC, Gebhart GF, Marcus ML, Brody MJ: Coronary Constrictor Pathway from Lateral Hypothalamus (LH) Projects Through Ventrolateral Medulla (VLM). Fed Proc, 45(3):397, 1986.

9. Gutterman DD, Clothier J, Brody MJ: Coronary Vasoconstriction Produced by Epicardial Hypothermic Solutions. Circulation, 74(4):II-243, 1986.

10. Gutterman DD, Clothier J, Marcus ML, Brody MJ: Coronary Vascular Response to Epicardial Hypothermic Solutions. Clin Res, 34(4):894A, 1986.

11. Gutterman DD, Marcus ML, Brody MJ, Miller FJ: Parabrachial Nuclear Region: An Important Neuronal Site Mediating Coronary Vasoconstriction. Circulation, 79:II-316, 1988.

12. Gutterman DD, Miller FJ, Morgan DA: Does Myocardial Stunning Alter Neurally-Mediated Coronary Vasoconstriction? Circulation, 78:II-555, 1988.

13. Stuhlmuller JE, Gutterman DD, Marcus ML, Gebhart GF, Brody MJ: Electrical Stimulation in Rostral Ventrolateral Medulla of the Cat Produces Coronary Vasoconstrictor and Vasodilator Responses. FASEB J, 2:A495, 1988.

14. Paul RK, Gutterman DD, Marcus ML, Brody MJ: Medullary Sites Projecting to Spinal Preganglionic Neurons Mediate Coronary Constriction in Cat. Circulation, 80:II-311, 1989.

15. Gutterman DD, Pardubsky PD, Gebhart GF: Attenuation of Afferent Spinal Neuronal Responses to Successive Coronary Occlusions May Contribute to Silent Ischemia. Circulation, 80:II-553, 1989.

16. Gutterman DD, Marcus ML, Brody MJ: Participation of Parabrachial Nuclear Region in Baroreflex Coronary Vasoconstriction. FASEB J., 3:A975, 1989.

17. De Boel SL, Gutterman DD: Is Coronary Vasocon¬striction a Component of the Cerebral Ischemic Response? Circulation, 80:II-552, 1989.

18. LaMaster TS, Paul RK, Gutterman DD: Coronary Constrictor Pathway From Anterior Hypothalamus Projects Through Rostroventrolateral Medulla. Clin Res, 37:882A, 1989.

19. Gutterman DD, Ben-Haim S, Morgan DA: Brief Myocardial Ischemia Alters the Coronary Vascular Response to Vagal Stimulation. FASEB J, 4:A402, 1990.

20. Paul RK, Gutterman DD, Brody MJ. Induction of Neurogenic coronary vasoconstriction from spinal cord is asymmetrical. Circ 82: III-636, 1990.

21. Gutterman DD, Barber CE, Morgan DA. Effect of Neuropeptide Y on transmural distribution of myocardial blood flow. Circ 82 (Suppl. III): III-336, 1990.

22. Law HI, Jones LF, Brody MJ, Gutterman DD. Differential regional vascular responses to electrical and chemical activation in rostral ventrolateral medulla.

23. Cave A, Gutterman DD: Role of Cell Bodies in the Region of Parabrachial Nucleus in Baroreflex Coronary Vasoconstriction. FASEB, 1991.

24. Nair BA, Paul RK, Murad Y, Gutterman DD, Brody MJ: Does the Area Postrema Mediate Ouabain-Induced Coronary Vasoconstriction? FASEB J, 5:A1113, 1991.

25. McDermott DA, Mellen ST, Gebhart GF, Gutterman DD: Pericardial Administration of Bradykinin (BK) to Rats Produces a Receptor-Mediated Reflex Change in Mean Arterial Pressure. FASEB, 1991.

26. Cave AR, LaMaster TS, Gutterman DD: Coronary Constrictor Pathway from Anterior Hypothalamus Includes Neurons in Rostroventrolateral Medulla. American Heart Association, 64th Scientific Sessions, 1991.

27. Gutterman DD, Morgan DA, Dellsperger KC: Differential Coronary Response to Norepinephrine and Sympa¬thetic Stimulation in Diabetic Dogs. American Heart Associ¬ation, 64th Scientific Sessions. Circulation, 84:II-558, 1991.

28. Goodson AR, Liebold JM, Gutterman DD. Sustained coronary vasoconstriction during electrical activation in anterior hypothalamus in rats.

29. Dellsperger KC, Brooks LA, Eastham CL, Gutterman DD: Coronary Microvascular Vasodilator Responses in Diabetic Dogs. American Heart Association, 64th Scientific Sessions, Circulation, 84:II-557, 1991.

30. McDermott DA, Meller ST, Gebhart GF, Gutterman DD: Characterization of the Reflex Hemodynamic Response to Intrapericardial Bradykinin. FASEB J., 6:A1293, 1992.

31. Ben-Haim S, Kienzle M, Gutterman DD. Beat by beat ECG variability for detection of patients with positive electrophysiologic study.

32. Ben-Haim SA, Becker B, Kaplinsky E, Gutterman DD, Palti Y. Prediction of immediate ventricular fibrillation following by QRS variability coronary artery ligation in dogs. J Am Coll Cardiol 20: 1270-1276, 1992.

33. Goodson AR, Leibold JM, Gutterman DD: Gliben¬clamide Produces Coronary Constriction in Cat. FASEB J, 6:A1753, 1992.

34. Dellsperger KC, Brooks LA, Gutterman DD: Hyperglycemia Attenuates Coronary Microvascular Dilation to Acetylcholine. FASEB J, 6(4):A1580, 1992.

35. Goodson AR, Leibold JM, Gutterman DD: Inhibition of Nitric Oxide Synthesis Augments Centrally-Induced Sympathetic Coronary Vasoconstriction in Cats. Circulation 86(4):I-509, 1992.

36. Dellsperger KD, Brooks LA, Gutterman DD: Enhanced Coronary Microvascular Vasodilation to an ATP-Sensitive Potassium Channel Opener in Diabetes. Circulation, 86(4):I-486, 1992.

37. Gutterman DD, Leibold JM, Morgan DA: Do Oxygen-Derived Free Radicals Contribute to Neural Stunning in the Heart? Circulation, 86(4):I-689, 1992.

38. Dellsperger KC, Brooks LA, Gutterman DD. Enhanced coronary microvascular vasodilation to an ATP-sensitive potassium channel opener in diabetes.

39. Dellsperger KC, Brooks LA, Morgan DA, Gutterman DD. Adenosine responses are not impaired in the coronary circulation of diabetic dogs.

40. Pettersen MD, Morgan DA, Leibold JM, Ben-Haim S, Gutterman DD: Sustained Reduction in Coronary Constriction to Sympathetic Stimulation Following Intracoronary Adenosine. FASEB J., 7:A212, 1993.

41. Miller FJ, Dellsperger KC, Gutterman DD: Hyperglycemia Alters Endothelium Dependent Relaxation of Coronary Microvessels but not Conduit Vessels In Vitro. FASEB J., 7:A423, 1993.

42. Dellsperger KC, Brooks LA, Gutterman DD: Hyperglycemia Results in Enhanced Coronary Microvascular Responses to RP 52891. FASEB J., 7:A423, 1993.

43. Miller FJ, Dellsperger KC, Embrey RP, Gutterman DD. Acetylcholine constricts isolated human coronary resistance vessels.

44. Miller FJ, Dellsperger KC, Embrey RP, Gutterman DD. Isolated human coronary arterioles exhibit myogenic tone.

45. Miller FJ, Dellsperger KC, Embrey RP, Gutterman DD: Differential Effect of Acetylcholine on Atrial and Ventricular Resistance Vessels Isolated from Human Hearts. JACC, 2/94:427A.

46. Oltman CL, Gutterman DD, Dellsperger KC. Glycoslated hemoglobin impairs coronary microvascular responses to acetylcholine in vitro.

47. Ammar Jr RF, Gutterman DD, Dellsperger KC. Coronary microvascular responses to metabolic stimulation in diabetes.

48. Miller FJ, Dellsperger KC, Oltman CL, Gutterman DD.: Alloxan-Induced Diabetes Mellitus Impairs Endothelium Dependent Vasodilation of Canine Coronary Arterioles. Circulation, 90:I-430, 1994.

49. Abe T, Morgan DA, Gutterman DD: Specific Role of Adenosine Receptors in Mediating Post-Ischemic Dysfunction of Coronary Sympathetic Innervation. Circulation 90:I-269, 1994.

50. Ammar Jr RF, Gutterman DD, Dellsperger KC: Topically Applied Superoxide Dismutase and Catalase Normalize Coronary Arteriolar Responses to Acetylcholine in Diabetes Mellitus In Vivo. Circulation, 90:I-574, 1994.

51. Ammar RF, Gutterman DD, Dellsperger KC: Effect of Superoxide Dismutase (SOD) on Microvascular Acetylcholine (ACh) Responses in Diabetes. FASEB J., 8:A292, 1994.

52. Sundaram K, Liebold JM, Gutterman DD: Inhibition of NO Synthase Augments Sympathetic Coronary Vasoconstriction to Stellate Stimulation in Cats. FASEB J., 8:A847, 1994.

53. Abe T, Morgan DA, Gutterman DD: Post-Ischemic Dysfunction of Sympathetic Coronary Innervation Involves Adenosine Receptor Activation. FASEB J., 8:A848, 1994.

54. Rodriguez-Iglesias E, Miller FJ, Dellsperger KC, Gutterman DD: Role of Prostaglandins and Nitric Oxide in the Human Atrial Coronary Arteriolar Response to Acetylcholine. FASEB J., 10(4):A912, 1995.

55. Abe T, Morgan DA, Gutterman DD: Effects of Activating Selective Adenosine Receptors on Sympathetic Coronary Innervation. FASEB J., 9(4):A840, 1995.

56. Paul RK, Breu M, Gutterman DD. Laterality of neurogenic coronary vasoconstriction in male and female cats.

57. Abe T, Sengupta JN, Gebhart GF, Gutterman DD: Reduced Cardiac Sympathetic Afferent Activity Following Brief Ischemia. Circ, 92:I-60, 1995.

58. Abe T, Morgan DA, Gutterman DD: Protection by Nerve Growth Factor Against Postischemic Dysfunction of Sympathetic Coronary Innervation. Circ., 92:I-60, 1995.

59. Miller FJ, Dellsperger KC, Gutterman DD: Mechanism of Human Coronary Arteriolar Relaxation to Adenosine Diphosphate. Circ., 92:I-131, 1995.

60. Miller FJ, Dellsperger KC, Gutterman DD: Basal Tone of Isolated Human Coronary Arterioles Depends on Protein Kinase C Activation. Circ., 92:I-430, 1995.

61. Ammar Jr RF, Gutterman DD, Dellsperger KC. Mechanisms of impaired dilation of coronary arterioles during increases in myocardial oxygen consumption in diabetes mellitus.

62. Miura H, Chappell DA, Gutterman DD: Preserved Dilation in Carotid Arteries of Apolipoprotein (APO)E and APOE + LOL Receptor Deficient Mice. FASEB J., 10:A604, 1996

63. Scott E, Breu M, Gutterman DD: Coronary Arteriolar Response to Norepinephrine in Humans. FASEB J, 10:A47, 1996.

64. Bocker J, Chappell DC, Gutterman DD: Selective Impairment of Endothelium Dependent Vasodilation Following Responses to Oxidized Low Density Lipoprotein. FASEB J, 10:A604, 1996.

65. Oltman CL, Gutterman DD, Dellsperger KC. Role of superoxide in impaired endothelium-dependent vasodilation of coronary arterioles from diabetic dogs.

66. Miura H, McCoy DM, Gutterman DD: Human Coronary Arteriolar Relaxation to Arachidonic Acid Depends upon Cytochrome P450 Monooxygenase. Circ., 94:I-63, 1996.

67. Miura H, Miller FJ, McCoy DM, Gutterman DD: Mechanism of Human Coronary Arteriolar Relaxation to Bradykinin. Circ., 94:I-241, 1996.

68. Miller FJ, Gutterman DD, Davidson BL: Adenovirus Mediated Gene Transfer to Isolated Canine and Human Coronary Conduit and Resistance Vessels. Circ., 94:I-243, 1996.

69. Miura H, Chappell DA, Gutterman DD: Mechanisms of Impaired Endothelium-Dependent Vasodilation in Carotid Arteries of Apolipoprotein E and LDL Receptor-Deficient Mice. Circ., 94:I-425, 1996.

70. Miller FJ, Dellsperger KC, Gutterman DD: Protein Kinase C Dependent Myogenic Constriction of Isolated Human Coronary Arterioles. Circ., 94:I-489, 1996.

71. Oltman CL, Gutterman DD, Quinn KA, Bar RS, Dellsperger KC. Insulin and IGF-1 induced vasodilation in canine coronary microvessels.

72. Miura H, Gutterman DD: Role of Ca2+-Activated Potassium Channels in Human Coronary Arteriolar Relaxation to Bradykinin. FASEB J, 11:A44, 1997.

73. Murphy SL, Beasley K, Gutterman DD: Circulating Factor in Diabetic Serum Contributes to Impaired Endothelial Dependent Dilation. FASEB J, 11:A157, 1997.

74. Miller Jr FJ, Gutterman DD, Heistad DD, Davidson BL. Gene transfer of superoxide dismutase reduces superoxide anion but does not improve endothelial dependent relaxation in atherosclerosis.

75. Miller Jr FJ, Mozena JD, Gutterman DD, Davidson BL. In Situ visualization of reactive oxygen species in atherosclerosis.

76. Miura H, Breu M, Gutterman DD. Hypoxia induces human coronary arteriolar dilation via ATP-sensitive potassium channel activation. Circ 96:I-74, 1997.

77. Miura H, Gutterman DD. Human coronary arteriolar dilation to bradykinin depends upon hyperpolarization via Ca2+-activated potassium channel activation. Circ 96:I-16, 1997.

78. Miura H, Breu M, Gutterman DD. Diabetes mellitus impairs ATP-sensitive potassium channel function of human coronary arterioles. Circ 96:I-17, 1997.

79. Gutterman DD, Breu M. Flow-mediated vasodilation of human coronary arterioles does not require nitric oxide synthase. Circ 96: I-310, 1997.

80. Manthei SA, Rupert BE, Gutterman DD. Thrombin induced vasodilation does not require activation of pertussis toxin-sensitive g-proteins. FASEB J. 12:A670, 1998.

81. Miura H, Gutterman DD. Membrane hyperpolization and vasodilation of human coronary arterioles to arachidonic acid (AA) via cytochrome P450 monooxygenase (P450). FASEB J.

82. Terata K, Miura H, Gutterman DD. Potent Vasodilation to Adrenomedullin in Isolated Human Coronary Arterioles. FASEB J. 12: A405, 1998.

83. Miura H, Manthei SA, Gutterman DD. Flow-induced dilation depends upon membrane hyperpolarization via Ca2+-activated K+ (KCa) channels in human coronary arterioles. Circ 98:I-138, 1998.

84. Miller FJ, Mozena JE, Foresman EL, Davidson BL, Gutterman DD. Smooth muscle cell production of superoxide is increased in atherosclerosis. Circ 98:I-311, 1998.

85. Terata K, Yorek MA, Gutterman DD. Acetylcholine-induced arteriolar dilation mediated by K-channel is reduced in STZ-induced diabetic rats with motor nerve dysfunction. Circ 98:I-400, 1998.

86. Miller FJ, Mozena J, Foresman EL, Gutterman DD, Davidson BL. Superoxide production is increased throughout the vascular wall of atherosclerotic mice aorta and mediated by a membrane bound NADPH oxidase. Circ 98:I-733, 1998.

87. Terata K, Miller FJ, Gutterman DD. Effect of superoxide on K-channel mediated responses in human coronary arterioles. Circ 98:I-825, 1998.

88. Oltman CL, Kern TS, Brooks LA, Kane NL, Gutterman DD, Dellsperger KC. Vascular reactivity of coronary arterioles from 5 year diabetic dogs. FASEB J 13:A88, 1999.

89. Terata K, Liu Y, Gutterman DD. Minimal contribution of superoxide to myogenic constriction of rat small coronary arteries. Circulation 100:I417-I418, 1999.

90. Liu Y, Terata K, Gutterman DD. Elevated glucose generates superoxide and reduces voltage-dependent K=channel current in rat coronary artery vascular smooth muscle cells. FASEB J 14:A163, 2000.

91. Liu Y, Terata K, Nicolosi A, Gutterman DD. Peroxynitrite inhibits human coronary arteriolar dilation to activation of Ca2+-activated K+ channels. Circulation 102:II-113, 2000.

92. Liu Y, Terata K, Gutterman DD. High glucose reduces voltage-dependent K+ current by NADPH oxidase-generated superoxide. Circulation 102:II-255, 2000.

93. Terata K, Mirua H, Sato A, Liu Y, Gutterman DD. Minimal contribution of nitric oxide (NO) and Katp channels to adenosine-induced dilation of coronary arterioles in patients with coronary artery disease. Circulation 102:II-255, 2000.

94. Chai Q, Gutterman DD, Liu Y. Elevated Glucose Impairs cAMP Mediated Dilation by Reducing Voltage-dependent K+ (Kv) Channel Activity in Coronary Vascular Smooth Muscle Cells (VSMCs). FASEB Journal, V15, No. 5: A764, 2001.

95. Miura H, Sato A, Gutterman DD. K+-Induced Dilation Involves Both Na+/K+ ATPase and Inwardly Rectifying K+ Channels (KIR) in Human Coronary Arterioles. FASEB Journal, V15, No. 5: A765, 2001.

96. Sato A, Miura H, LiuY, Chai Q, Somberg LB, Eberhardt LM, Gutterman DD. Gender based differences in endothelium dependent vasodilation of human arterioles. FASEB Journal, V15, No. 5: A1122, 2001.

97. Liu Y, Chai Q, Gutterman DD. Peroxynitrite Inhibits Ca2+-Activated K+ Channel Activity in Smooth Muscle of Human Coronary Arterioles. Circulation, V104, No. 17: II-31, 2001.

98. Miura H, Sato A, Saito T, Miura M, Gutterman DD. Evidence for Multiple Endothelium-Derived Hyperpolarizing Factors in Human Coronary Arterioles. Circulation, V104, No. 17: II-39, 2001.

99. Miura H, Saito T, Miura M, Gutterman DD. Diazoxide Protects against Hypoxia/Ischemia-Induced Injury in Human Coronary Arterioles in Vitro. Circulation, V104, No. 17: II-114, 2001.

100. Miura H, Qiang C, Liu Y, Saito T, Miura M, Gutterman DD. Flow-Mediated Dilation of Human Coronary Arterioles Involves Production of Hydrogen Peroxide. Circulation, V104, No. 17: II-285-6, 2001.

101. Sato A, Miura H, Liu Y, Gutterman DD. Differential Regulation of the Human Coronary Arterioles by Adenosine Receptor Subtypes. Circulation, V104, No. 17: II-287, 2001.

102. Sato A, Miura H, Liu Y, Nicolosi AC, Sakuma I, Gutterman DD. Involvement of Intermediate Conductance Ca2+-Activated K+ Channels in Adenosine-Induced Human Coronary Arteriolar Dilation. FASEB Journal, V16, No. 5: A860, 2002.

103. Li H, Gutterman DD, Liu Y. Elevated Glucose Impairs cAMP-mediated Voltage-dependent K+ (Kv) Channel Activity in Coronary Vascular Smooth Muscle Cells (VSMCs). FASEB Journal, V16, No. 5: A860, 2002.

104. Miura H, Sato A, Saito T, Miura M, Gutterman DD. Oxidative Stress Impairs ATP-Sensitive Potassium Channel (KATP)-Mediated Dilation of Human Coronary Arterioles (HCA) in Diabetes Mellitus (DM). FASEB J, V16, No. 5: A860, 2002.

105. Liu YP, Li H, Stadnicka A, Suzuki A, Kwok W, Bosnjak Z, Gutterman DD. Differential Response of KATP Channels to Superoxide in Coronary and Cardiac Myocytes. Circulation, V106, No. 19: II-35, 2002.

106. Sato A, Miura H, Liu Y, Nicolosi A, Gutterman DD. Reactive Oxygen Species Mediate Vasodilation of Human Coronary Arterioles. Circulation, V106, No. 19: II-111, 2002.

107. Liu Y, Zhao H, Kalyanaraman B, Johnson D, Gutterman DD. Mitochondria, a Source for Generating H2O2 Plays a Key Role in Flow-Mediated Dilation in Human Coronary Arterioles. Circulation, V106, No. 19: II-171, 2002.

108. Sato A, Miura H, Liu Y, Downey FX, Gutterman DD. Oxidative Stress Enhances Human Coronary Arteriolar Dilation to Adenosine. Circulation, V106, No. 19: II-277, 2002.

109. Liu Y, Li H, Stadnicka A, Suzuki A, Kwok W, Bosnjak Z, Gutterman DD. Differential Response of KATP Channels to Superoxide in Coronary and Cardiac Myocytes. Circulation, V106, No. 19: II-35, 2002.

110. Sato A, Miura H, Liu Y, Nicolosi A, Gutterman DD. Reactive Oxygen Species Mediate Vasodilation of Human Coronary Arterioles. Circulation, V106, No. 19: II-111, 2002.

111. Liu Y, Zhao H, Li H, Kalyanaraman B, Johnson D, Gutterman DD. Mitochondria, a Source for Generating H2O2, Plays a Key Role in Flow-Mediated Dilation in Human Coronary Arterioles. Circulation, V106, No. 19: II-171, 2002.

112. Sato A, Miura H, Liu Y, Downey FX, Gutterman DD. Oxidative Stress Enhances Human Coronary Arteriolar Dilation to Adenosine. Circulation, V106, No. 19: II-277, 2002.

113. Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Microvascular dysfunction in inflammatory bowel disease- IBD. FASEB Journal, V17, No. 4: A69, 2003.

114. Ou H, Ou Z, Jones DW, Ackerman AW, Hillery CA, Gutterman DD, Guice KS, Oldham KT, Pritchard KA. 4F, An Apo A-I mimetic preserves acetylcholine-induced vasodilation of carotid arterioles in sickle cell disease mice. FASEB J, V17, No. 4: A371, 2003.

115. Li H, Liu Y, Gutterman DD. High glucose causes tyrosine nitration of Kv1.2 and Kv1.5 in rat coronary arterial vascular smooth muscles cells (VSMCs). FASEB J, V17, No. 4: A505, 2003.

116. Liu Y, Li H, Gutterman DD. Complex I and III of electron transport chains play a key role in flow-mediated dilation in human coronary arterioles. FASEB J, V17, No. 4: A506, 2003.

117. Sato A, Miura H, Liu Y, Reuben C, Gutterman DD. Adenosine-induced vasodilation in coronary arterioles from subjects with diabetes: Effect of reactive oxygen species. FASEB J, V17, No. 4: A508, 2003.

118. Miura H, Saito T, Gutterman DD. Shear stress induces endothelial generation and release of hydrogen peroxide (H2O2) in human coronary arterioles (HCA). FASEB J, V17, No. 4: A509, 2003.

119. Ou J, Ou Z, Jones DW, Weihrauch D, Ackerman AW, Gutterman DD, Guice AS, Oldham KT, Pritchard KA. An Apo A-I mimetic peptide preserves vasodilation in hypercholesterolemic mice. FASEB J, V17, No. 4: A513, 2003.

120. Miura H, Sato A, Saito T, Abu-Hatoum O, Gutterman DD. Adenosine Acts as an Endothelium-Derived Hyperpolarizing Factor in Human Coronary Arteriolar Dilation to Adenosine 5'-Diphosphate. Circulation, V108, No. 17: IV-99, 2003.

121. Miura H, Saito T, Fujiwara Y, Sato A, Abu-Hatoum O, Gutterman DD. Upregulation of Intermediate Conductance Calcium-Activated Potassium Channels is Associated with Altered Human Coronary Arteriolar Reactivity. Circulation, V108, No. 17: IV-102, 2003.

122. Sato A, Miura H, Abu-Hatoum O, Bosnjac JJ, Gutterman DD. Different Mechanisms of Dilation to Extracellularly and Intracellularly Produced Hydrogen Peroxide in Human Coronary Arterioles. Circulation, V108, No. 17: IV-102, 2003.

123. Liu Y, Li H, Gutterman DD. Cytoskeletal Elements are Critical in Flow-Mediated Dilation in Human Coronary Arterioles. Circulation, V108, No. 17: IV-227, 2003.

124. Chen Y, Gao Y, Cook C, Raza A, Biller J, Gutterman DD, Medhora M, Jacobs ER. Activation of eNOS in bovine pulmonary artery endothelial cells by VEGF and 20-HETE. FASEB J, V18, No. 5: A1238, 2004.

125. Miura H, Gutterman DD. Interaction of Two Distinct Endothelium-Derived Hyperpolarizing Factors in the Human Coronary Microcirculation. Circulation, V110, No. 17: III-181, 2004.

126. Hatoum OA, Binion DG, Miura H, Bosnjak JJ, Otterson MF, Telford G, Gutterman DD. Role for hydrogen peroxide in Ach-induced dilation of human intestinal microvessels. FASEB J, Vol. 18, No. 4: A624, 2004.

127. Liu Y, Mass M, Newman DK, Newman PK, Gutterman DD. Nitric oxide plays a more predominant role in flow-mediated dilation in coronary arteries of PECAM-1-knockout mice. FASEB J, Vol. 18, No. 4: A269-270, 2004.

128. Liu Y, Gutterman DD. Cellular Origin of EDHF (H2O2) Released from Human Coronary Arterioles in Response to Shear Stress. Circ, V110, No. 17: III-76, 2004.

129. Miura H, Toyama K, Hatoum OA, Gutterman DD. Adenosine Mediates Human Coronary Arteriolar Dilation to Adenosine 5'-triphosphate (ATP). FASEB J, Vol. 19, No. 4: A688, 2005.

130. Larsen BT, Miura HM, Campbell WB, Falck JR, Gutterman DD. Epoxyeicosatrienoic acids induce vasodilation of human coronary arterioles via an iberiotoxin-sensitive mechanism. FASEB J, Vol. 19, No. 4: A727, 2005.

131. Liu Y, Bubolz AB, Newman PJ, Newman DK, Gutterman DD. Ebselen restores the endothelium derived hyperpolarizing factor (EDHF) component of coronary flow-mediated dilation in PECAM-1-knockout mice. FASEB J, Vol. 19, No. 5: A1259, 2005.

132. Hatoum OA, Binion DG, Miura H, Phillips S, Gutterman DD. Nitric oxide (NO) assessment in control and chronically inflamed inflammatory bowel disease (IBD) submucosal intestinal microvessels. FASEB J, Vol. 19, No. 5: A1265, 2005.

133. Phillips SA, Somberg LB, Otterson MF, Telford GL, Nicolosi AC, Gutterman DD. Effect of Coronary Artery Disease (CAD) on Flow Induced Dilation in Human Visceral Adipose Resistance Vessels. FASEB J, Vol. 19, No. 5: A1265, 2005.

134. Liu Y, Gutterman DD. Evidence for H2O2 as the EDHF Mediating Flow-Induced Dilation in Human Coronary Arterioles. Circulation, Vol. 112, No. 17: II-216, 2005.

135. Liu Y, Bienengraeber M, Bubolz A, Gutterman DD. High Glucose Reduces Kv1.5 Channel Activity by Disrupting Protein Translocation in Coronary Smooth Muscle Cells. Circulation, Vol. 112, No. 17: II-216, 2005.

136. Larsen BT, Otterson MF, Miura H, Phillips SA, Selle RM, Gutterman DD, Hatoum OA. Radiation impairs endothelium-dependent dilation of murine intestinal arterioles via reduction of nitric oxide by reactive oxygen species. FASEB J, V20, No. 5: A1162, 2006.

137. Bubolz AH, Wu Q, Gutterman DD, Liu Y. Ebselen Reduces Kv1 Channel Nitration and Restores Kv1 Channel Function in Diabetic Rat Coronary Arteries. FASEB J, V20, No. 4: A284, 2006.

138. Hatoum OA, Binion DG, Miura H, Larsen BT, Selle RM, Kopelman D, Gutterman DD. The complex role of hydrogen peroxide (H202) in acetylcholine-induced dilation of human mucosal intestinal microvessels. FASEB J, V20, No. 4: A282-283, 2006.

139. Miura H, Toyama K, Hatoum OA, Saito T, Gutterman DD. Down-regulation of Intermediate Conductance Calcium-activated Potassium Channel (IKCa) Inhibits Human Coronary Smooth Muscle Cell (HSMC) Proliferation. FASEB J, V20, No. 5: A1176, 2006.

140. Phillips SA, Jacquelyn KP, Syed AQ, Syed AA, Pleuss JP, Jurva JW, Gutterman DD. Do low fat and low carbohydrate diets show similar improvement in endothelial function? FASEB J, V20, No. 5: A1392, 2006.

141. Larsen BT, Miura H, Campbell WB, Gutterman DD. NADPH Oxidase-Derived Reactive Oxygen Species Reduce Cytochrome P450 Mediated Dilation of Human Coronary Arterioles. Circulation, Vol. 114, No. 18: II-246, 2006.

142. Zhang DX, Bubolz AH, Gutterman DD. Activation of TRPV4 Channels Dilates Human Coronary Arterioles: Role of Ca2+ Influx and Mitochondrial Redox Signaling. Circulation, Vol. 114, No. 18: II-247, 2006.

143. Bubolz AH, Zhang X, Liu Y, Gutterman DD. Nitric Oxide Inhibits Flow-mediated Dilation in Human Coronary Arterioles by Regulating Mitochondrial Production of Reactive Oxygen Species. Circulation, Vol. 114, No. 18: II-20, 2006.

144. Toyama K, Hatoum OA, Gutterman DD, Miura H. Role of CD73, Ecto-5' Nucleotidases, in Human Coronary Arteriolar Dilation to Adenine Nucleotides. Circulation, Vol. 114, No. 18: II-20, 2006.

145. Phillips SA, Somberg LB, Hatoum OA, Gutterman DD. Mechanisms of hydrogen peroxide induced vasoconstriction in human adipose resistance arteries. FASEB J, V21, No. 5: A491, 2007.

146. Toyama K, Saito T, Fujiwara Y, Hatoum OA, Gutterman DD, Miura H. Intermediate Conductance Calcium-activated Potassium Channel, KCa3.1, Plays an Important Role in Macrophage (MO) Migration in Atherosclerosis. FASEB J, V21, No. 6: A854, 2007.

147. Zhang DX, Bubolz AH, Gauthier KM, Campbell WB, Gutterman DD. TRPV4 channel-mediated Ca2+ entry and vasodilatation in small bovine coronary arteries. FASEB J, V21, No. 6: A859, 2007.

148. Bubolz AH, Zhang DX, Larsen BT, Gutterman DD. TRPV4 mediates flow-induced dilation in human coronary arterioles. FASEB J, V21, No. 6: A1234, 2007.

149. Phillips SA, Syed AQ, Syed AY, Das EK, Jurva JW, Gutterman DD. Resistance and aerobic exercise protects against endothelial dysfunction induced by acute exertion. FASEB J, V21, No. 6: A935, 2007.

150. Larsen BT, Phillips SA, Bubolz AH, Zielonka J, Kalyanaraman B, Gutterman DD. HPLC separation of hydroethidine products: a specific and sensitive method for quantifying microvascular superoxide. FASEB J, 2007 21:5;577.2.

151. Wittenburg AL, Phillips SA, Gutterman DD. The role of catalase and endothelium in hydrogen peroxide induced vasodilatation of human adipose arterioles. FASEB J, Late-Breaking, LB99: 2007.

152. Miura H, Toyama K, Fujiwara Y, Saito T, Hatoum OA, Gutterman DD. Intermediate-conductance Calcium-activated Potassium Channel, KCa3.1, Plays an Important role in Macrophage Migration in Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference, Chicago, IL, 2007.

153. Larsen BT, Bubolz AH, Pritchard Jr KA, Gutterman DD. Endothelial NADPH oxidase mediates bradykinin-induced dilation of human coronary arterioles. 8th World Conference for Microcirculation, Milwaukee, WI, 2007.

154. Zhang DX, Bubolz A, Mendoza S, Gutterman DD. TRPV4 channel mediates flow-induced dilation in mouse small mesenteric arteries. FASEB J 2008 22:964.9.

155. Wittenburg AL, Phillips S, Gutterman DD. Catalase inhibition effect on exogenous hydrogen peroxide induced vasoconstriction in diseased human arterioles. FASEB J 2008 22:1148.15.

156. Mendoza SA, Gutterman DD, Bubolz A, Suzuki M, Zhang DX. Role of TRPV4 channels in agonist-induced endothelial Ca2+ entry and vasodilation: Evidence from TRPV4-deficient mice. FASEB J. 2008 22:1181.4.

157. Larsen BT, Campbell WB, Gutterman DD. 12- and 15-hydroxyeicosatetraenoic acids may function as endothelium-derived hyperpolarizing factors in the human coronary microcirculation. FASEB J. 2008 22:914.8.

158. Das EK, Gutterman DD, Phillips SA. Exercise Protects Against Endothelial Dysfunction During Oral Glucose and High Fat Load. FASEB J. 2008 22:1235.14.

159. Migrino RQ, Bright M, Pajewski N, Truran S, Gutterman DD, Hari P. Abstract 2400: Late Gadolinium Enhancement on MRI is a Prognostic Marker of Poor Survival in Light Chain Amyloidosis: Results from Long-Term Follow Up. Circulation, Oct 2008; 118: S_718.

160. Migrino RQ, Hari P, Bright M, Phillips S, Truran S, Wittenburg A, Wang J, Gutterman DD. Abstract 2401: Endothelial Dysfunction and Oxidative Stress in Human Coronary Microvasculature Following Acute Exposure to AL Amyloid Light Chains: New Mechanism of Amyloid Injury. Circulation, Oct 2008; 118: S_718 - S_719.

161. Wang J, Gutterman DD, Widlansky ME. Abstract 410: Mitochondrial Uncoupling with CCCP Reverses Acute Hyperglycemia Induced Endothelial Dysfunction in Human Arterioles Circulation, Oct 2008; 118: S_299.

162. Gutterman DD. 2008 George E. Brown Memorial Lecture--Flow-Induced Vasodilation in the Human Heart: Unique Endothelial Mechanisms and Clinical Insights Circulation, Oct 2008; 118: A_11.

163. Wittenburg AL, Mendoza SA, Zhang DX, Gutterman DD. Unmasking a role for nitric oxide in acetylcholine-induced vasodilation in diseased human coronary arterioles. FASEB J. Apr 2009 23:LB73.

164. Zinkevich NS, Wittenburg AL, Gutterman DD. Role of mitochondria in flow-induced dilation of human adipose arterioles from subjects with and without coronary artery disease. FASEB J. Apr 2009 23:1006.3.

165. Larsen BT, Miura H, Campbell WB, Gutterman DD. 12- and 15-Hydroxyeicosatetraenoic Acids (HETEs) Function as Endothelium-Derived Hyperpolarizing Factors (EDHFs) in Human Coronary Arterioles. FASEB J. Apr 2009 23:952.17.

166. Gutterman DD. Endothelial function and cardiovascular risk. Clinical Cardiology. Oct 2009 32:15.

167. Zinkevich NS, Gutterman DD. Effect of Nitric Oxide Synthase and growth conditions on hydrogen peroxide production in cultured endothelial cells during shear stress. FASEB J. April 6, 2010 24:602.6.

168. Larsen BT, Mendoza SA, Campbell WB, Gutterman DD. Lipoxygenases mediate endothelium-dependent vasodilation in the human coronary microcirculation. FASEB J. April 6, 2010 24:1028.

169. Truran S, Gutterman DD, Schlundt B, Hari P, Migrino RQ. Oxidative Stress and Apoptotic Injury Induced by Amyloidogenic Light Chain Proteins in Human Coronary Artery Endothelial Cells. AHA Scientific Sessions, Session on Microcirculation and Cerebral/Coronary/Peripheral Circulation. November 15, 2010.

170. Zinkevich NS, Wittenburg AL, Gutterman DD. Role of Cyclooxygenase in flow-induced dilation of human coronary arterioles depends upon age. Circulation. November 2010 122: A15764.

171. Larsen B, Mendoza SA, Campbell WB, Gutterman DD. Vasomotor regulation of the human coronary circulation by hydroxyepoxyeicosatrienoic and trihydroxyeicosatrienoic acids. FASEB J March 17, 2011 25:lb467.

172. Zhang DX, Mendoza SA, Gebremedhin D, Gutterman DD. H2O2 dilates human coronary arterioles by stimulating the large-conductance Ca2+-activated K+ channel activity FASEB J March 17, 2011 25:1093.5.

173. Zinkevich NS, Gutterman DD. Role of mitochondrial reactive oxygen species on flow-induced dilation in human arterioles with coronary artery disease. FASEB J March 17, 2011 25:832.8.

174. Mendoza SA, Borbouse R, Gauthier KM, Campbell WB, Gutterman DD, Zhang DX. 5,6-Epoxyeicosatrienoic acid-induced endothelium-dependent dilation of mouse mesenteric arteries: dependence on TRPV4 channel activity FASEB J March 17, 2011 25:820.7.

175. Franco D, Truran S, Gutterman DD, Georges J, Hari P, Migrino RQ. Novel mechanism of endothelial cell injury by light chain amyloidosis proteins through nuclear translocation of apoptosis inducing factor. ATVB. Chicago, IL. April 28-30, 2011.

176. Borbouse R, Gutterman DD. Influence of obesity on insulin-mediated dilation in the human microcirculation. FASEB J March 29, 2012 26:866.2.

177. Durand M, Phillips S, Gutterman DD. The Vascular Renin Angiotensin System Contributes to Endothelial Dysfunction Induced by Acute High Pressure in Human Adipose Microvessels FASEB J March 29, 2012 26:676.8.

178. Zinkevich N, Zhang D, Gutterman DD. NADPH oxidase-dependent reactive oxygen species are involved in flow-induced dilation of human adipose arterioles FASEB J March 29, 2012 26:863.3.

179. Beyer A, Gutterman DD. Decreased Telomerase Activity Converts the Mechanism of FMD from NO to H2O2 in Human and Mouse Arterioles FASEB J March 29, 2012 26:676.1.

180. Zinkevich N, Gutterman DD, Zhang D. Role of hydrogen peroxide and epoxyeicosatrienoic acids in arachidonic acid-induced dilation of human coronary arterioles. FASEB J. April 9, 2013 27:687.12.

181. Zheng X, Yoshinori N, Gutterman DD, Zhang D. Arachidonic acid-induced dilation in human coronary arterioles: role of endothelial TRPV4-mediated and membrane potential-sensitive Ca2+ entry FASEB J March 29, 2012 26:1056.3.

182. Freed J, Beyer A, and Gutterman DD. Inhibition of Neutral Sphingomyelinase Prevents High Pressure-Induced Shift in the Mediator of Endothelium-Dependent Dilation from NO to H2O2. FASEB J. April 9, 2013 27:901.1.

183. Durand M, Beyer A, Hockenberry J, Gutterman DD. Inhibition of the vascular renin-angiotensin system preserves nitric oxide-mediated vasodilation in human adipose arterioles after transient high pressure stress (676.9). FASEB J. April 2014 28:676.9.

184. Santos J, Gutterman DD, Beyer A. Mitochondrial telomerase regulates flow mediated dilation by suppressing mitochondrial derived free radical production (664.1). FASEB J. April 2014 28:664.1.

185. Freed JK, Hockenberry JC, & Gutterman DD. Manipulation of the Sphingolipid Rheostat Alters the Mediator of Flow-Induced Dilation in the Human Microcirculation. Circulation. 2014;130:A16304

186. Gupta N, Elixhauser A, Bangalore S, & Gutterman DD. Incidence and Outcomes of Hospitalizations Associated With Adverse Effects of Anticoagulation in Therapeutic Use. Circulation. 2014;130:A15647

187. Durand MJ & Gutterman DD. Mechanical Shear Stress Restores Mitochondrial Cytoarchitecture in Human Endothelial Cells Exposed to Angiotensin II by Modulating Activity of the Fission-Inducing Protein Dynamin Related Protein 1. Circulation. 2014;130:A12625

188. Sengupta J, Kannampalli P, Belligoli A, Rousso B, Ben-Haim S, Gutterman DD. Cardiac Vagal Afferent Response in Rats during Cardiac Contractility Modulation (CCM. FASEB J. April 2015 29:651.6.

189. Durand M, Gutterman DD, Beyer A. Vasodilator and Vasoprotective Actions of Angiotensin 1-7 in the Human Microcirculation – Role of Telomerase. FASEB J. April 2015 29:789.3.

190. Hockenberry J, Zinkevich N, Beyer A, Gutterman DD. Acute and Chronic Inhibition of NOS Causes a Switch in Vasodilator Mechanism from Nitric Oxide to Hydrogen Peroxide in the Human Microcirculation. FASEB J. April 2015 29:794.2.